<SEC-DOCUMENT>0001193125-25-220647.txt : 20250926
<SEC-HEADER>0001193125-25-220647.hdr.sgml : 20250926
<ACCEPTANCE-DATETIME>20250926161844
ACCESSION NUMBER:		0001193125-25-220647
CONFORMED SUBMISSION TYPE:	POS EX
PUBLIC DOCUMENT COUNT:		13
FILED AS OF DATE:		20250926
DATE AS OF CHANGE:		20250926
EFFECTIVENESS DATE:		20250926

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WESTERN ASSET HIGH INCOME FUND II INC.
		CENTRAL INDEX KEY:			0001058239
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		POS EX
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285996
		FILM NUMBER:		251350826

	BUSINESS ADDRESS:	
		STREET 1:		620 EIGHTH AVENUE
		STREET 2:		47TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		8887770102

	MAIL ADDRESS:	
		STREET 1:		620 EIGHTH AVENUE
		STREET 2:		47TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON BROTHERS HIGH INCOME FUND II INC
		DATE OF NAME CHANGE:	19980421

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON BROTHERS HIGH YIELD BOND FUND IN
		DATE OF NAME CHANGE:	19980319
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS EX
<SEQUENCE>1
<FILENAME>d879285dposex.htm
<DESCRIPTION>WESTERN ASSET HIGH INCOME FUND II INC
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:cik0001058239="http://www.sec.com/20250926" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Western Asset High Income Fund II Inc</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P09_26_2025To09_26_2025" id="ixv-1046">0001058239</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P09_26_2025To09_26_2025" id="ixv-1047">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cik0001058239-20250926.xsd"/></ix:references><ix:resources><xbrli:context id="P09_26_2025To09_26_2025"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001058239</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-26</xbrli:startDate> <xbrli:endDate>2025-09-26</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001058239</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-09-26</xbrli:startDate> <xbrli:endDate>2025-09-26</xbrli:endDate> </xbrli:period> </xbrli:context></ix:resources></ix:header></div><div><div style="line-height:normal;display: inline;"><div style="max-width:100%;text-align:left"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">As filed <div style="display:inline;">with </div>the Securities and Exchange Commission on September&#160;26, 2025 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:right">Securities Act Registration No.&#160;<ix:nonNumeric name="dei:EntityFileNumber" contextRef="P09_26_2025To09_26_2025" id="ixv-1065">333-285996</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:right">Investment Company Act Registration <div style="white-space:nowrap;display:inline;">No.&#160;<ix:nonNumeric name="dei:InvestmentCompanyActFileNumber" contextRef="P09_26_2025To09_26_2025" id="ixv-1066">811-08709</ix:nonNumeric></div> </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:4pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, <div style="display:inline;">D</div>.C. 20549 </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:DocumentType" contextRef="P09_26_2025To09_26_2025" id="ixv-1067">N-2</ix:nonNumeric></div> </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:4.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman;font-weight:bold;text-align:center">REGISTRATION STATEMENT </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">UNDER </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">THE SECURITIES ACT OF 1933 </div></div><ix:nonNumeric name="dei:DocumentRegistrationStatement" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1068">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">Pre-Effective</div> Amendment No. </div><ix:nonNumeric name="dei:PreEffectiveAmendment" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1069">&#9744;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;">Post-Effective Amendment No.&#160;<ix:nonNumeric name="dei:PostEffectiveAmendmentNumber" contextRef="P09_26_2025To09_26_2025" id="ixv-1070">1</ix:nonNumeric> </div><ix:nonNumeric name="dei:PostEffectiveAmendment" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1071">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">and/or </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:15pt; font-family:Times New Roman;font-weight:bold;text-align:center">REGISTRATION STATEMENT </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">UNDER </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">THE INVESTMENT COMPANY ACT OF 1940 </div></div><ix:nonNumeric name="dei:InvestmentCompanyActRegistration" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1072">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;">Amendment No.&#160;<ix:nonNumeric name="dei:InvestmentCompanyRegistrationAmendmentNumber" contextRef="P09_26_2025To09_26_2025" id="ixv-1073">14</ix:nonNumeric> </div><ix:nonNumeric name="dei:InvestmentCompanyRegistrationAmendment" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1074">&#9746;</ix:nonNumeric><div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"> </div></div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P09_26_2025To09_26_2025" id="ixv-1075">Western Asset High Income Fund II Inc.</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter) </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P09_26_2025To09_26_2025" id="ixv-1076">One Madison Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="P09_26_2025To09_26_2025" id="ixv-1077">17th Floor</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P09_26_2025To09_26_2025" id="ixv-1078">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:stateprovnameen" id="ixv-1079">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P09_26_2025To09_26_2025" id="ixv-1080">10010</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="P09_26_2025To09_26_2025" id="ixv-1081">888</ix:nonNumeric>) <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P09_26_2025To09_26_2025" id="ixv-1082">777-0102</ix:nonNumeric></div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code) </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" id="ixv-1083">Jane Trust</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Franklin Templeton </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" id="ixv-1084">One Madison Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" id="ixv-81">17<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">th</div> Floor</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" id="ixv-1085">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen" id="ixv-1086">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" id="ixv-1087">10010</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name and Address of Agent for Service) </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">Copies to: </div></div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<td style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">David W. Blass, Esq.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Ryan P. Brizek, Esq.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Debra Sutter, Esq.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Simpson Thacher&#160;&amp; Bartlett LLP</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">900 G Street NW</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20001</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Marc A. De Oliveira, Esq.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Franklin Templeton</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">100 First Stamford Place</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8.5pt; font-family:Times New Roman;font-weight:bold;text-align:center">Stamford, CT 06902</div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;">Approximate Date of Proposed Public Offering: </div><ix:nonNumeric name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic" contextRef="P09_26_2025To09_26_2025" id="ixv-1088">From time to time after the effective date of this Registration Statement.</ix:nonNumeric> </div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, check the following box&#8194;<ix:nonNumeric name="dei:DividendOrInterestReinvestmentPlanOnly" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1089">&#9744;</ix:nonNumeric>. </div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If any of the securities being registered on this form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933, other than securities offered in connection with a dividend reinvestment plan, check the following box.&#8194;<ix:nonNumeric name="dei:DelayedOrContinuousOffering" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1090">&#9746;</ix:nonNumeric> </div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto, check the following box&#8194;<ix:nonNumeric name="cef:PrimaryShelfFlag" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1091">&#9746;</ix:nonNumeric>. </div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box&#8194;<ix:nonNumeric name="dei:EffectiveUponFiling462e" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1092">&#9744;</ix:nonNumeric>. </div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box&#8194;<ix:nonNumeric name="dei:AdditionalSecuritiesEffective413b" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1093">&#9744;</ix:nonNumeric>. </div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">It is proposed that this filing will become effective (check appropriate box) </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:EffectiveWhenDeclaredSection8c" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1094">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">when declared effective pursuant to Section&#160;8(c) </div></td></tr></table><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">If appropriate, check the following box: </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:NewEffectiveDateForPreviousFiling" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1095">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This post-effective amendment designates a new effective date for a previously filed registration statement. </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:AdditionalSecurities462b" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1096">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act and the Securities Act registration statement number of the earlier effective registration statement for the same offering is &#8195;&#8195;&#8195; . </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:NoSubstantiveChanges462c" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1097">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is &#8195;&#8195;&#8195; . </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:ExhibitsOnly462d" contextRef="P09_26_2025To09_26_2025" format="ixt:fixed-true" id="ixv-1098">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration statement number of the earlier effective registration statement for the same offering is <ix:nonNumeric name="dei:ExhibitsOnly462dFileNumber" contextRef="P09_26_2025To09_26_2025" id="ixv-1099">333-285996</ix:nonNumeric>. </div></td></tr></table><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman">Check each box that appropriately characterizes the Registrant: </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="cef:RegisteredClosedEndFundFlag" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1100">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund <div style="white-space:nowrap;display:inline;">(closed-end</div> company that is registered under the Investment Company Act of 1940 (&#8220;Investment Company Act&#8221;)). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="cef:BusinessDevelopmentCompanyFlag" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1101">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Business Development Company <div style="white-space:nowrap;display:inline;">(closed-end</div> company that intends or has elected to be regulated as a business development company under the Investment Company Act). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="cef:IntervalFundFlag" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1102">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Interval Fund (Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund or a Business Development Company that makes periodic repurchase offers under Rule <div style="white-space:nowrap;display:inline;">23c-3</div> under the Investment Company Act). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="cef:PrimaryShelfQualifiedFlag" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1103">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:yesnoballotbox" id="ixv-1104">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1105">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Emerging Growth Company (as defined by Rule <div style="white-space:nowrap;display:inline;">12b-2</div> under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#9744;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of Securities Act. </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left"><ix:nonNumeric name="cef:NewCefOrBdcRegistrantFlag" contextRef="P09_26_2025To09_26_2025" format="ixt-sec:boolballotbox" id="ixv-1106">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). </div></td></tr></table><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:8.5pt; font-family:Times New Roman;font-weight:bold">The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that the Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such dates as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine. </div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="max-width:100%;text-align:left"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div><div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="width:8.5in;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXPLANATORY NOTE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Post-Effective Amendment No.&#160;1 to the Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File <span style="white-space:nowrap">Nos.&#160;333-285996</span> and <span style="white-space:nowrap">811-08709)</span> of Western Asset High Income Fund II Inc. (the &#8220;Registration Statement&#8221;) is being filed pursuant to Rule&#160;462(d) under the Securities Act of&#160;1933, as amended (the &#8220;Securities Act&#8221;), solely for the purpose of filing exhibits to the Registration Statement. Accordingly, this <span style="white-space:nowrap">Post-Effective</span> Amendment No.&#160;1 consists only of a facing page, this explanatory note and Part C of the Registration Statement on <span style="white-space:nowrap">Form&#160;N-2</span> setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No.&#160;1 does not modify any other part of the Registration Statement. Pursuant to Rule&#160;462(d) under the Securities Act, this Post-Effective Amendment No.&#160;1 shall become effective immediately upon filing with the Securities and Exchange Commission. The contents of the Registration Statement are hereby incorporated by reference. </p>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART C </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OTHER INFORMATION </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 25. Financial Statements and Exhibits </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Financial Statements for the fiscal year ended April&#160;30, 2025 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">Part&#8201;A</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Financial Highlights </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">Part&#8201;B</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated into Part B by reference to Registrant&#8217;s most recent Certified Shareholder Report on Form <span style="white-space:nowrap">N-CSR,</span> filed July&#160;5, 2024 (File <span style="white-space:nowrap">No.&#160;811-08709):</span> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">&#8201;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Schedule of Investments as of April&#160;30, 2025 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">&#8201;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Statement of Assets and Liabilities as of April&#160;30, 2025 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">&#8201;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Statement of Operations for the Year Ended April&#160;30, 2025 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">&#8201;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Statement of Changes in Net Assets for the Year Ended April&#160;30, 2025 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">&#8201;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Notes to Financial Statements for the Year Ended April&#160;30, 2025 </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:7%;vertical-align:top;text-align:left">&#8201;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Report of Independent Registered Public Accounting Firm for the Year Ended April&#160;30, 2025 </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:96%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;white-space:nowrap">(2)&#8194;&#8201;&#8202;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Exhibits</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(a)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/0000950130-98-002769.txt">Amended and Restated Articles of Incorporation<sup style="font-size:75%; vertical-align:top">(1)</sup></a><sup style="font-size:75%; vertical-align:top">&#160;</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(a)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000091485107000255/item77q1amendment.txt">Articles of Amendment, dated September&#160;20, 2006<sup style="font-size:75%; vertical-align:top">(2)</sup></a><sup style="font-size:75%; vertical-align:top">&#160;</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(a)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312525208918/d940540dex99a3.htm">Articles of Amendment, dated September 19, 2025<sup style="font-size:75%; vertical-align:top">(8)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(b)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312524262629/d826281d8k.htm">Fourth Amended and Restated Bylaws<sup style="font-size:75%; vertical-align:top">(3)</sup></a><sup style="font-size:75%; vertical-align:top">&#160;</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(c)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(d)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Articles V and VIII of Registrant&#8217;s Articles of Incorporation are incorporated herein by reference.</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(e)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312522078650/d635104dex99e.htm">Dividend Reinvestment Plan<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">4</sup><sup style="font-size:75%; vertical-align:top">)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(f)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(g)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522078650/d635104dex99g1.htm">Investment Management Agreement between the Registrant and Franklin Templeton Fund Adviser, LLC<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup></a><sup style="font-size:75%; vertical-align:top">)</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(g)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522078650/d635104dex99g2.htm">Subadvisory Agreement between Franklin Templeton Fund Adviser, LLC and Western Asset Management Company, LLC<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(g)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522078650/d635104dex99g3.htm">Subadvisory Agreement between Western Asset Management Company, LLC and Western Asset Management Company Limited<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(g)(4)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522078650/d635104dex99g4.htm">Subadvisory Agreement between Western Management Company, LLC and Western Asset Management Company Pte. Ltd.<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a><span style="text-decoration:underline">&#160;</span></td></tr></table>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">

<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:96%"/></tr>

<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(h)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d879285dex99h.htm">Amended and Restated Sales Agreement* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(i)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(j)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312522078650/d635104dex99j1.htm">Custodian Services Agreement with The Bank of New York Mellon, dated January&#160;1, 2018<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a><sup style="font-size:75%; vertical-align:top">&#160;</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(j)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312522078650/d635104dex99j2.htm">Amendment No.&#160;9 to the Custodian Services Agreement, dated May&#160;1, 2021, with The Bank of New York Mellon, dated January&#160;1, 2018<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a><sup style="font-size:75%; vertical-align:top">&#160;</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312522078650/d635104dex99k1.htm">Transfer Agency and Services Agreement with Computershare Inc., dated March&#160;14, 2016<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a><sup style="font-size:75%; vertical-align:top">&#160;</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312522078650/d635104dex99k2.htm">Amendment No.&#160;9 to the Transfer Agency and Services Agreement, dated March&#160;19, 2021, with Computershare Inc., dated March&#160;14, 2016<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">5</sup><sup style="font-size:75%; vertical-align:top">)</sup></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522100384/d340298dex99k15.htm">Form of Funds of Funds Investment Agreement<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">4</sup><sup style="font-size:75%; vertical-align:top">)</sup></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(4)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522301881/d406551dex99k3.htm">The Margin Loan and Security Agreement with Bank of America, N.A.<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">6</sup><sup style="font-size:75%; vertical-align:top">)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(k)(5)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1058239/000119312522301881/d406551dex99k4.htm">Amendment No.&#160;1 to the Margin Loan and Security Agreement with Bank of America, N.A.<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">6</sup><sup style="font-size:75%; vertical-align:top">)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(l)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Opinion and Consent of Venable LLP<sup style="font-size:75%; vertical-align:top">(8)</sup></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(l)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d879285dex99l2.htm">Opinion and Consent of Venable LLP* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(m)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(n)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312525208918/d940540dex99n.htm">Consent of Independent Registered Public Accounting Firm<sup style="font-size:75%; vertical-align:top">(8)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(o)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(p)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(q)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Not Applicable</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(r)(1)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312525208918/d940540dex99r1.htm">Code of Ethics of the Fund and the Manager<sup style="font-size:75%; vertical-align:top">(8)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(r)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312525208918/d940540dex99r2.htm">Code of Ethics of Western Asset<sup style="font-size:75%; vertical-align:top">(8)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(s)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312525208918/d940540dexfilingfees.htm">Filing Fee Table<sup style="font-size:75%; vertical-align:top">(8)</sup> </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(t)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/0001058239/000119312521361029/d207382dex99s1.htm">Power of Attorney<sup style="font-size:75%; vertical-align:top">(</sup><sup style="font-size:75%; vertical-align:top">7</sup><sup style="font-size:75%; vertical-align:top">)</sup></a></td></tr>
</table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(1)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on May&#160;21, 1998 with <span style="white-space:nowrap">Pre-Effective</span> Amendment No.&#160;2 to the Registrant&#8217;s Registration Statement on <span style="white-space:nowrap">Form&#160;N-2</span> (File <span style="white-space:nowrap">Nos.&#160;333-48351</span> and <span style="white-space:nowrap">811-08709)</span> and incorporated by reference herein </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(2)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed as Exhibit 99 <span style="white-space:nowrap">to&#160;NSAR-B&#160;as</span> filed with the Commission on June&#160;29, 2007 and incorporated herein by reference </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(3)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on November&#160;20, 2024 with <span style="white-space:nowrap">Form&#160;8-K&#160;and</span> incorporated by reference herein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(4)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on April&#160;8, 2022 with the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File Nos. <span style="white-space:nowrap">333-261721</span> and <span style="white-space:nowrap">811-08709)</span> and incorporated by reference herein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(5)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on March&#160;18, 2022 with the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File Nos. <span style="white-space:nowrap">333-261721</span> and <span style="white-space:nowrap">811-08709)</span> and incorporated by reference herein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(6)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on December&#160;9, 2022 with the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File Nos. <span style="white-space:nowrap">333-261721</span> and <span style="white-space:nowrap">811-08709)</span> and incorporated by reference herein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(7)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on March&#160;21, 2025 with the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2</span> (File Nos. 333-285996 and <span style="white-space:nowrap">811-08709)</span> and incorporated by reference herein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">(8)</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed on September 19, 2025 with the Registrant&#8217;s Registration Statement on Form N-2 (File No. 333-285996 and 811-08709) and incorporated by reference herein. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">*</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed herewith </p></td></tr></table>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 26. Marketing Arrangements </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made to the sales agreement for the Registrant&#8217;s common stock incorporated by reference herein or the form of underwriting agreement to be filed as an exhibit in a post-effective amendment to the Registrant&#8217;s Registration Statement and the section entitled &#8220;Plan of Distribution&#8221; contained in Registrant&#8217;s Prospectus incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 27. Other Expenses of Issuance and Distribution </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:87%"/>

<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">22,659</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Industry Regulatory Authority fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">22,700</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">10,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">160,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">$</td>
<td style="vertical-align:bottom;text-align:right">215,359</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&#160;</p></td>
<td>&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 28. Persons Controlled by or Under Common Control with Registrant </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 29. Number of Holders of Securities </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At July&#160;31, 2025: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:68%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:83%"/>

<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Title of Class</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"><span style="font-weight:bold">Number of</span><br/><span style="font-weight:bold">Record&#160;Holders</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock, par value $0.001 per share</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:right">24,949</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 30. Indemnification </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Maryland law permits a Maryland corporation to include in its charter a provision eliminating the liability of its directors and officers to the corporation and its stockholders for money damages except for liability resulting from actual receipt of an improper benefit or profit in money, property or services or active and deliberate dishonesty that is established by a final judgment and is material to the cause of action. The Registrant&#8217;s Charter contains such a provision that eliminates such liability to the maximum extent permitted by Maryland law. In addition, the Registrant has provisions in its Charter and the Bylaws that obligate the Registrant, to the maximum extent permitted by Maryland law, to indemnify any present or former Director or officer from and against any claim or liability to which that person may become subject or which that person may incur by reason of his or her status as a present or former Director or officer of the Registrant and to pay or reimburse their reasonable expenses in advance of final disposition of a proceeding. Pursuant to the Bylaws, absent a court determination that an officer or Director seeking indemnification was not liable on the merits or guilty of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office, the decision by the Registrant to indemnify such person will be based upon the reasonable determination of independent counsel or nonparty Independent Directors, after review of the facts, that such officer or Director is not guilty of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his office. </p>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liability arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 31. Business and Other Connections of Adviser </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The descriptions of the Manager, Western Asset, Western Asset Limited and Western Asset Singapore under the caption &#8220;Management of the Fund&#8221; in the Prospectus and Statement of Additional Information of this registration statement are incorporated by reference herein. Information as to the directors and officers of the Manager, Western Asset, Western Asset Limited and Western Asset Singapore, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the directors and officers of the Manager, Western Asset, Western Asset Limited and Western Asset Singapore in the last two years, is included in their respective applications for registration as an investment adviser on Form ADV (File Nos. <span style="white-space:nowrap">801-66785,</span> <span style="white-space:nowrap">801-08162,</span> <span style="white-space:nowrap">801-21068</span> and <span style="white-space:nowrap">801-67298,</span> respectively) filed under the Investment Advisers Act of 1940, as amended, and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 32. Location of Accounts and Records </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accounts and records of the Registrant are maintained at the office of the Registrant at One Madison Avenue, 17th Floor, New York, New York 10010. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 33. Management Services </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Not applicable. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item 34. Undertakings </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Not applicable. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Not applicable. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The Registrant undertakes: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) to file, during a period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(1) to include any prospectus required by Section&#160;10(a)(3) of the Securities Act; </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(2) to reflect in the prospectus any facts or events after the effective date of the registration statement (or the most recent post- effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement. </p>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(3) to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Provided, however,</span> that paragraphs a(1), a(2), and a(3) of this section do not apply to the extent the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference into the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) that, for the purpose of determining any liability under the Securities Act, each post-effective amendment to this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of those securities at that time shall be deemed to be the initial bona fide offering thereof; </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) that, for the purpose of determining liability under the Securities Act to any purchaser: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) if the Registrant is relying on Rule 430B [17 CFR 230.430B]: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) if the Registrant is subject to Rule 430C: each prospectus filed pursuant to Rule 424(b) under the Securities Act as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </p>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser: </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Registrant undertakes that, for the purpose of determining any liability under the Securities Act: </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in the form of prospectus filed by the Registrant under Rule 424(b)(1) shall be deemed to be a part of this registration statement as of the time it was declared effective; and </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) each post-effective amendment that contains a form of prospectus will be deemed to be a new registration statement relating to the securities offered therein, and the offering of the securities at that time shall be deemed to be the initial bona fide offering thereof. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. The Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any prospectus or Statement of Additional Information. </p>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;) and the Investment Company Act of 1940, as amended, the Registrant has duly caused this Amendment to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York on the 26th day of September, 2025. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">WESTERN ASSET HIGH INCOME FUND II INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:top">/s/ Jane Trust</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Director, Chief Executive Officer and President</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the 1933 Act, this Amendment to the Registration Statement has been signed by the following person in the capacity and on the date indicated. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td style="width:35%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:31%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signature</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date</p></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Jane E. Trust</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Jane Trust</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">President, Chief Executive Officer and Director (Principal Executive Officer)</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September&#160;26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Christopher Berarducci</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Christopher Berarducci</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Treasurer and Principal Financial Officer</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Robert D. Agdern*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Robert D. Agdern</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Carol L. Colman*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Carol L. Colman</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Anthony Grillo*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Anthony Grillo</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Eileen A. Kamerick*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Eileen A. Kamerick</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chair, Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Nisha Kumar*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Nisha Kumar</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Peter Mason*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Peter Mason</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Hillary A. Sale*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:center">Hillary A. Sale</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center">September 26, 2025</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0">


<tr>

<td style="width:10%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:89%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">*By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jane Trust</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Jane Trust</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">As Agent or <span style="white-space:nowrap"><span style="white-space:nowrap">Attorney-in-fact</span></span></td></tr>
</table> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&#160;26, 2025 </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The original power of attorney authorizing Jane Trust to execute this Registration Statement, and any amendments thereto, for the Directors of the Registrant on whose behalf this Registration Statement was filed on March 21, 2025 as an exhibit to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2.</span> </p>
</div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="max-width:100%;text-align:left">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Schedule of Exhibits to Form <span style="white-space:nowrap">N-2</span> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:8%"/>
<td style="width:91%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(h)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d879285dex99h.htm">Amended and Restated Sales Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">(l)(2)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"><a href="d879285dex99l2.htm">Opinion and Consent of Venable LLP&#160;</a></td></tr>
</table>
</div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(H)
<SEQUENCE>2
<FILENAME>d879285dex99h.htm
<DESCRIPTION>AMENDED AND RESTATED SALES AGREEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Amended and Restated Sales Agreement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WESTERN ASSET HIGH INCOME FUND II INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CAPITAL ON DEMAND<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AMENDED AND RESTATED SALES AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">September&nbsp;26, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JonesTrading
Institutional Services LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">325 Hudson Street, 6<SUP STYLE="font-size:75%; vertical-align:top">th </SUP>Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10013 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Western Asset High Income Fund II Inc., a Maryland corporation (the &#8220;<B><U>Fund</U></B>&#8221;), Franklin Templeton Fund Adviser, LLC, a
Delaware limited liability company (f/k/a Legg Mason Partners Fund Advisor, LLC, the &#8220;<B><U>Manager</U></B>&#8221;), Western Asset Management Company, LLC, a California limited liability company (the &#8220;<B><U>Subadviser</U></B>&#8221;) and
JonesTrading Institutional Services LLC (&#8220;<B><U>Jones</U></B>&#8221;) previously entered into a Capital on Demand<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Sales Agreement dated December&nbsp;9, 2022 (the &#8220;<B><U>Original
Agreement</U></B>&#8221;). The parties hereby amend and restate the Original Agreement and collectively confirm their agreement in the form of this Capital on Demand<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Amended and Restated
Sales Agreement (this &#8220;<B><U>Agreement</U></B>&#8221;), which supersedes and replaces the Original Agreement, as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&#8195;<U>Issuance and Sale of Shares</U>. The Fund agrees that, from time to time during the term of this Agreement, on the terms and
subject to the conditions set forth herein, it may issue and sell through Jones, acting as agent and/or principal, the Fund&#8217;s common stock, par value $0.001 per share (the &#8220;<B><U>Shares</U></B>&#8221;) having an aggregate offering price
of up to $185,000,000. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this <U>Section</U><U></U><U>&nbsp;1</U> on the number of Shares issued and sold under this
Agreement shall be the sole responsibility of the Fund, and Jones shall have no obligation in connection with such compliance. The issuance and sale of Shares through Jones will be effected pursuant to the Registration Statement (as defined below)
filed by the Fund and declared effective by the Securities and Exchange Commission (the &#8220;<B><U>Commission</U></B>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Fund
has entered into a Management Agreement with the Manager dated as of July&nbsp;31, 2020, a Custodian Services Agreement with The Bank of New York Mellon, dated as of January&nbsp;1, 2018, as amended, and a Transfer Agency and Services Agreement
between the Fund, </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Computershare Inc. and Computershare Trust Company, N.A, dated as of March&nbsp;14, 2016, and such agreements are herein referred to as the &#8220;<B><U>Management Agreement</U></B>,&#8221; the
&#8220;<B><U>Custodian Agreement</U></B>,&#8221; and the &#8220;<B><U>Transfer Agency Agreement</U></B>,&#8221; respectively. Collectively, the Management Agreement, the Custodian Agreement and the Transfer Agency Agreement are herein referred to as
the &#8220;<B><U>Fund Agreements</U></B>.&#8221; The Manager has entered into a Subadvisory Agreement with the Subadviser dated July&nbsp;31, 2020 (the &#8220;<B><U>Subadvisory Agreement</U></B>&#8221;). The Subadviser has entered into a Subadvisory
Agreement with Western Asset Management Company Limited, a corporation organized under the laws of England and Wales (the &#8220;<B><U>UK Subadviser</U></B>&#8221;), dated as of July&nbsp;31, 2020, and a Subadvisory Agreement with Western Asset
Management Company Pte. Ltd., a corporation organized under the laws of Singapore (the &#8220;<B><U>Singapore Subadviser</U></B>&#8221;, together with the UK Subadviser, the &#8220;<B><U><FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
Subadvisers</U></B>&#8221;, and together with the Subadviser, the &#8220;<B><U>Subadvisers</U></B>&#8221;), dated as of July&nbsp;31, 2020, and such agreements are herein referred to together as the
&#8220;<B><U><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Subadvisory Agreements</U></B>,&#8221; and together with the Subadvisory Agreement, the &#8220;<B><U>Subadvisory Agreements</U></B>.&#8221; In addition, the Fund has adopted a dividend
reinvestment plan (the &#8220;<B><U>Dividend Reinvestment Plan</U></B>&#8221;) pursuant to which holders of shares of the Fund&#8217;s common stock shall have their dividends automatically reinvested in additional shares of common stock of the Fund
unless they elect to receive such dividends in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-right:1%; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Fund (a)&nbsp;has filed, in accordance with the provisions of
the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively, the &#8220;<B><U>Securities Act</U></B>&#8221;) and the Investment Company Act of 1940, as amended, and the rules and regulations thereunder
(collectively, the &#8220;<B><U>Investment Company Act</U></B>&#8221;), with the Commission a registration statement on Form <FONT STYLE="white-space:nowrap">N-2</FONT> (File Nos. 333-285996 and 811-08709) (the &#8220;<B><U>Original Registration
Statement</U></B>&#8221;), and (b)&nbsp;may file, in accordance with the provisions of the Securities Act and the Investment Company Act, with the Commission one or more subsequent registration statements on Form
<FONT STYLE="white-space:nowrap">N-2,</FONT> including, in each case, a base prospectus (&#8220;<B><U>Basic Prospectus</U></B>&#8221;), with respect to the Shares and which incorporated by reference certain documents that the Fund has filed or will
file in accordance with the provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#8220;<B><U>Exchange Act</U></B>&#8221;) and the Investment Company Act. The Fund shall prepare one or more
supplements to the Basic Prospectus relating to the Shares, including all documents incorporated by reference therein, to be filed with the Commission pursuant to Rule 424 under the Securities Act (collectively, the &#8220;<B><U>Prospectus
Supplement</U></B>&#8221;). The Fund shall furnish to Jones, for use by Jones, copies of the Basic Prospectus, as supplemented by the Prospectus Supplement, relating to the Shares. Except where the context otherwise requires, the Original
Registration Statement, as amended when it became effective, including all documents filed as part thereof and/or incorporated by reference therein, including the statement of additional information dated as of March&nbsp;23, 2022, and including any
information contained in a Prospectus Supplement subsequently filed with the Commission pursuant to Rule 424 under the Securities Act or deemed to be part of such registration statement pursuant to Rule 430B or Rule 430C of the Securities Act, or
any subsequent registration statement on Form <FONT STYLE="white-space:nowrap">N-2,</FONT> as amended when it becomes effective, including all documents filed as a part thereof and/or incorporated by reference therein and including any information
deemed to be part of such registration statement pursuant to Rule 430B or Rule 430C of the Securities Act, (i)&nbsp;filed pursuant to Rule&nbsp;415(a)(6) under the Securities Act by the Fund with respect to any securities registered pursuant to the
Original Registration Statement, including any Placement Shares (as defined below), as a result of the end of the three-year period described in Rule 415(a)(5) under the Securities Act or (ii)&nbsp;to register any additional Shares to be issued and
sold under this Agreement is herein called the &#8220;<B><U>Registration Statement.</U></B>&#8221; The Basic </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus, as it may be supplemented by the Prospectus Supplement, in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the Fund with the Commission
pursuant to Rule 424 under the Securities Act, and in each case including all documents incorporated by reference therein, is herein called the &#8220;<B><U>Prospectus</U></B>.&#8221; Any reference herein to the Registration Statement, the Basic
Prospectus, the Prospectus or any amendment or supplement thereto, including the Prospectus Supplement, shall be deemed to refer to and include the documents incorporated or deemed to be incorporated by reference therein, and any reference herein to
the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the
Commission pursuant to the Securities Act, the Exchange Act and the Investment Company Act, as applicable, deemed to be incorporated by reference therein (collectively, the &#8220;<B><U>Incorporated Documents</U></B>&#8221;). For purposes of this
Agreement, all references to the Registration Statement, the Prospectus, or to any amendment or supplement thereto shall be deemed to include any copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System
(&#8220;<B><U>EDGAR</U></B>&#8221;). For purposes of this Agreement, all references to the Registration Statement, unless otherwise noted and except as the context otherwise requires, should be deemed to include any and all amendments thereto filed
with the Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&#8195;<U>Placements</U>. Each time that the Fund wishes to issue and sell Shares hereunder (each, a
&#8220;<B><U>Placement</U></B>&#8221;), it will notify Jones by <FONT STYLE="white-space:nowrap">e-mail</FONT> notice (or other method mutually agreed to in writing by the parties) containing the parameters in accordance with which it desires the
Shares to be sold, which shall, at a minimum, include the number of Shares to be issued (the &#8220;<B><U>Placement Shares</U></B>&#8221;), the time period during which sales are requested to be made, any limitation on the number of Placement Shares
that may be sold in any one day and any minimum price below which sales may not be made (a &#8220;<B><U>Placement Notice</U></B>&#8221;), a form of which, containing such minimum sales parameters necessary, is attached hereto as <U>Schedule 1</U>.
The Placement Notice shall originate from any of the individuals from the Fund set forth on <U>Schedule 3</U> (with a copy to each of the other individuals from the Fund listed on such schedule), and shall be addressed to each of the individuals
from Jones set forth on <U>Schedule 3</U>, as such <U>Schedule 3</U> may be amended from time to time. The Placement Notice shall be effective upon receipt by Jones unless and until (i)&nbsp;in accordance with the notice requirement set forth in
<U>Section</U><U></U><U>&nbsp;4</U> and within one Business Day (as defined herein) of its receipt of the Placement Notice, Jones declines to accept the terms contained therein for any reason, in its sole discretion, (ii)&nbsp;the entire amount of
the Placement Shares have been sold, (iii)&nbsp;in accordance with the notice requirements set forth in <U>Section</U><U></U><U>&nbsp;4</U>, the Fund suspends or terminates the Placement Notice, (iv)&nbsp;the Fund issues a subsequent Placement
Notice with parameters superseding those on the earlier dated Placement Notice, or (v)&nbsp;the Agreement has been terminated under the provisions of <U>Section</U><U></U><U>&nbsp;11</U>. The amount of any discount, commission or other compensation
to be paid by the Fund to Jones in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in <U>Schedule 2</U>. It is expressly acknowledged and agreed that neither the Fund nor Jones will have
any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Fund delivers a Placement Notice to Jones and Jones does not decline, within the time period specified above, such Placement Notice pursuant to the
terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&#8195;<U>Sale of Placement Shares by Jones.</U> Subject to the terms and conditions
herein set forth, upon the Fund&#8217;s issuance of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended or otherwise terminated in accordance with the terms of this Agreement, Jones, for the
period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares up to the amount specified, and otherwise in accordance with the terms of
such Placement Notice. Jones will provide written confirmation to the Fund no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth
the number of Placement Shares sold on such day, the compensation payable by the Fund with respect to such sales, with an itemization of deductions made by Jones (as set forth in <U>Section</U><U></U><U>&nbsp;5(a)</U>) from the gross proceeds that
it receives from such sales, and the Net Proceeds (as defined below) payable to the Fund. The Fund and the Manager each acknowledge that Jones intends to sell the Placement Shares in privately negotiated transactions and/or any other method
permitted by law, including sales made directly on the New York Stock Exchange (the &#8220;<B><U>Exchange</U></B>&#8221;), the then-existing trading market for the Shares or sales made to or through a market maker or through an electronic
communications network, or in any other manner that may be deemed to be an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#8220;at-the-market&#8221;</FONT></FONT> offering as defined in Rule 415 under the Securities Act, in each
case at or above the then-current net asset value of the Fund&#8217;s common shares, exclusive of any distributing commission or discount, in accordance with Section&nbsp;23(b) of the Investment Company Act. To the extent that Jones acts as the
Fund&#8217;s agent with respect to any such sale, Jones covenants that it will comply with all prospectus delivery requirements imposed under applicable federal and state securities laws. The Fund and the Manager each acknowledge and agree that
(i)&nbsp;there can be no assurance that Jones will be successful in selling Placement Shares, and (ii)&nbsp;Jones will not incur any liability or obligation to the Fund, the Manager, the Subadviser or any other person or entity if it does not sell
Placement Shares for any reason other than a failure by Jones to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares as required under this <U>Section</U><U></U><U>&nbsp;3</U>.
For the purposes hereof, &#8220;<B><U>Trading Day</U></B>&#8221; means any day on which Shares are purchased and sold on the principal exchange or market on which the Shares are listed or quoted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&#8195;<U>Suspension of Sales</U>. The Fund or Jones may, upon notice to the other party in writing (including by <FONT
STYLE="white-space:nowrap">e-mail</FONT> correspondence to all of the individuals of the other party set forth on <U>Schedule 3</U> or by telephone (confirmed immediately by verifiable facsimile transmission or
<FONT STYLE="white-space:nowrap">e-mail</FONT> correspondence to all of the individuals of the other party set forth on <U>Schedule 3</U>)), suspend or refuse to undertake any sale of Placement Shares; <U>provided</U>, <U>however</U>, that such
suspension or refusal shall not affect or impair either party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. Each of the parties hereto agrees that no such notice shall be effective
against the other unless it is made to the individuals named on <U>Schedule 3</U> hereto in accordance with this <U>Section</U><U></U><U>&nbsp;4</U>, as such Schedule may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&#8195;<U>Settlement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Settlement of Placement Shares</U>. Unless otherwise specified in the applicable Placement Notice, settlement for sales of
Placement Shares will occur on the first (1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) Business Day (or such earlier day as is industry practice for <FONT STYLE="white-space:nowrap">regular-way</FONT> trading) following the date on
which such sales are made (each, a &#8220;<B><U>Settlement Date</U></B>&#8221;). The amount of proceeds to be delivered to the Fund on a Settlement Date against the receipt of the Placement Shares sold (the
</P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#8220;<B><U>Net Proceeds</U></B>&#8221;) will be equal to the aggregate sales price at which such Placement Shares were sold, after deduction for (i)&nbsp;Jones&#8217;s commission, discount or
other compensation for such sales payable by the Fund pursuant to <U>Section</U><U></U><U>&nbsp;2</U> hereof, (ii)&nbsp;Reimbursable Amounts (as defined herein), (iii) any other amounts due and payable by the Fund to Jones hereunder pursuant to
<U>Section</U><U></U><U>&nbsp;7(e)</U> hereof, and (iv)&nbsp;any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Delivery of Shares</U>. On or before each Settlement Date, the Fund will, or will cause its transfer agent to, electronically
transfer the Placement Shares being sold by crediting Jones&#8217;s or its designee&#8217;s account at The Depository Trust Company through its Deposit and Withdrawal at Custodian (&#8220;<B><U>DWAC</U></B>&#8221;) System or by such other means of
delivery as may be mutually agreed upon by the parties hereto and, upon receipt of such Placement Shares, which in all cases shall be freely tradable, transferable, registered shares in good deliverable form, Jones will deliver the related Net
Proceeds in same day funds to an account designated by the Fund prior to the Settlement Date. The Fund agrees that if the Fund defaults on its obligation to deliver Placement Shares on a Settlement Date, the Fund and the Manager each agree that, in
addition to and in no way limiting the rights and obligations set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U> hereto, it will (i)&nbsp;hold Jones harmless against any loss, claim, damage, or expense (including reasonable legal fees and
expenses), as incurred, arising out of or in connection with such default by the Fund and (ii)&nbsp;pay to Jones any commission, discount, or other compensation to which it would otherwise have been entitled absent such default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&#8195;<U>Representations and Warranties of the Fund, the Manager and the Subadviser</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Representations and Warranties by the Fund and the Manager</U>. The Fund and the Manager, jointly and severally, represent and
warrant to and agree with Jones as of the date hereof, as of each Representation Date (as defined in <U>Section</U><U></U><U>&nbsp;7(j)</U> below) and as of the time of each sale of Placement Shares pursuant to the Agreement (the
&#8220;<B><U>Applicable Time</U></B>&#8221;) as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&#8195;The Original Registration Statement has been declared
effective by the Commission under the Securities Act as of the date hereof. The Registration Statement is effective under the Securities Act as of each Representation Date. Each Prospectus included as part of the Registration Statement as originally
filed or as part of any amendment or supplement thereto or filed pursuant to Rule 424 under the Securities Act complied when so filed in all material respects with the provisions of the Securities Act and the Investment Company Act. The Commission
has not issued any order preventing or suspending the use of the Prospectus or the effectiveness of the Registration Statement and no proceedings for such purpose have been instituted or, to the knowledge of the Fund, are contemplated by the
Commission. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&#8195;(A) The Registration Statement in the form in which it became effective and also in such form as it
may be when any post-effective amendment thereto shall become effective and as of the date hereof, as of each Applicable Time and as of each Settlement Date, and (B)&nbsp;the Prospectus and any amendment or supplement thereto when filed with the
Commission pursuant to Rule 424 under the Securities Act and as of the date hereof, as of each Applicable Time and as of each Settlement Date, complied or will comply in all material respects with the provisions of the Securities Act and the
Investment Company Act, and each of the Registration Statement and the Prospectus did not or will not at any </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
such times contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of the
Prospectus, in light of the circumstances under which they were made) not misleading; except that this representation and warranty does not apply to statements in or omissions from the Registration Statement and the Prospectus made in reliance upon
and in conformity with information relating to Jones furnished to the Fund in writing by or on behalf of Jones expressly for use therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&#8195;Each Incorporated Document heretofore filed, when it was filed with the Commission complied in all material respects
with the requirements of the Exchange Act and<B> </B>the Investment Company Act, as applicable, and any further Incorporated Documents so filed and incorporated after the date of this Agreement will, when they are filed, comply in all material
respects with the requirements of the Exchange Act and<B> </B>the Investment Company Act, as applicable; no such Incorporated Document, at the time it was filed or hereafter is filed with the Commission contained or will contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; except that this representation and warranty
does not apply to statements in or omissions from the Incorporated Documents made in reliance upon and in conformity with information relating to Jones furnished to the Fund in writing by or on behalf of Jones for use therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&#8195;Each Additional Disclosure Item (as defined in <U>Section</U><U></U><U>&nbsp;6(a)(22)</U> hereof), does not and will
not conflict, in all material respects, with the information contained in the Registration Statement or the Prospectus and each such Additional Disclosure Item, as supplemented by and taken together with the Prospectus as of each Applicable Time and
each Settlement Date, did not and will not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading; except that this representation and warranty does not apply to statements in or omissions from any Additional Disclosure Item made in reliance upon and in conformity with information relating to Jones furnished to the Fund in writing by
or on behalf of Jones for use therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&#8195;The Fund has been duly organized and is validly existing in good standing
as a corporation under the laws of Maryland, with full corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus and is duly qualified to do
business and is in good standing under the laws of each jurisdiction which requires such qualification except where the failure to so register or qualify does not have a material adverse change in the condition (financial or otherwise), business
prospects, earnings, business or properties of the Fund, whether or not arising from transactions in the ordinary course of business (a &#8220;<B><U>Fund Material Adverse Effect</U></B>&#8221;). The Fund has no subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&#8195;The Fund&#8217;s authorized equity capitalization is as set forth in the Registration Statement and the Prospectus;
the capital stock of the Fund conforms in all material respects to the description thereof contained in the Registration Statement and the Prospectus; all outstanding shares of the Fund&#8217;s common stock have been duly and validly authorized and
issued and are fully paid and nonassessable; the Placement Shares have </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
been duly and validly authorized, and, when issued and delivered against payment therefor pursuant to this Agreement, will be validly issued and fully paid and nonassessable; the Placement Shares
are duly listed, and admitted and authorized for trading, subject to official notice of issuance and evidence of satisfactory distribution, on the Exchange; the certificates, if any, for the Placement Shares are in valid and sufficient form; the
holders of outstanding shares of the Fund&#8217;s common stock are not entitled to preemptive or other rights to subscribe for the Placement Shares; and, except as set forth in the Registration Statement or the Prospectus, no options, warrants or
other rights to purchase, agreements or other obligations to issue, or rights to convert any obligations into or exchange any securities for, shares of capital stock of or ownership interests in the Fund are outstanding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&#8195;The Fund&#8217;s registration statement on Form <FONT STYLE="white-space:nowrap">8-A</FONT> under the Exchange Act
has become effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&#8195;The Fund, subject to the Registration Statement having been declared effective and the
filing of the Prospectus under Rule 424, has taken all required action under the Securities Act, the Investment Company Act and the Exchange Act to make the public offering and consummate the sale of the Placement Shares as contemplated by this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&#8195;There are no agreements, contracts, indentures, leases, permits or other instruments, that are
required to be described in the Registration Statement or the Prospectus, or to be filed as an exhibit to the Registration Statement, which are not described or filed as required; the statements in the Registration Statement and the Prospectus on
the inside front cover and under the headings &#8220;Prospectus Summary,&#8221; &#8220;The Fund&#8217;s Investments,&#8221; &#8220;Leverage,&#8221; &#8220;Risks,&#8221; &#8220;Management of the Fund,&#8221; &#8220;Dividend Reinvestment Plan,&#8221;
&#8220;Description of Shares,&#8221; &#8220;Certain Provisions in the Charter and Bylaws,&#8221; &#8220;Certain United States Federal Income Tax Considerations&#8221; and &#8220;Investment Policies and Techniques,&#8221; insofar as such statements
summarize legal matters, agreements, documents or proceedings discussed therein, are accurate and fair summaries of such legal matters, agreements, documents or proceedings in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&#8195;The Fund has full corporate power and authority to enter into this Agreement and the Fund Agreements; the execution
and delivery of, and the performance by the Fund of its obligations under, this Agreement and the Fund Agreements have been duly authorized by the Fund and this Agreement and the Fund Agreements have been duly executed and delivered by the Fund.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&#8195;The Fund is duly registered under the Investment Company Act as a
<FONT STYLE="white-space:nowrap">closed-end,</FONT> <FONT STYLE="white-space:nowrap">non-diversified,</FONT> management investment company and the Fund&#8217;s notification of registration as an investment company under the Investment Company Act on
Form <FONT STYLE="white-space:nowrap">N-8A,</FONT> as amended from time to time (the &#8220;<B><U>Investment Company Act Notification</U></B>&#8221;) has been duly filed with the Commission. The Fund has not received any notice from the Commission
pursuant to <U>Section</U><U></U><U>&nbsp;8(e)</U> of the Investment Company Act with respect to the Investment Company Act Notification or the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&#8195;Other than as provided in <U>Section</U><U></U><U>&nbsp;6(a)(8)</U> above, no consent, approval, authorization,
filing with or order of any court or governmental agency or body is required </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
in connection with the transactions contemplated herein or in the Fund Agreements, except such as have been made or obtained under the Securities Act, the Exchange Act, the Advisers Act of 1940,
as amended, and the rules and regulations thereunder (the &#8220;<B><U>Advisers Act</U></B>&#8221;), the Investment Company Act, the rules and regulations of FINRA and the Exchange, and such as may be required under the blue sky laws of any
jurisdiction in connection with the purchase and distribution of the Placement Shares in the manner contemplated herein and in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13)&#8195;Neither the issuance and sale of the Placement Shares, the execution, delivery or performance of this Agreement or
any of the Fund Agreements, nor the consummation of the transactions herein or therein contemplated, nor the fulfillment of the terms hereof or thereof or the adoption of the Dividend Reinvestment Plan, conflict with, result in a breach or violation
of, or imposition of any lien, charge or encumbrance upon any property or assets of the Fund pursuant to, (i)&nbsp;the charter and bylaws of the Fund, (ii)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement,
loan agreement or other agreement, obligation, condition, covenant or instrument to which the Fund is a party or bound or to which its property is subject, or (iii)&nbsp;any statute, law, rule, regulation, judgment, order or decree applicable to the
Fund of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Fund or any of its properties except, in the case of (ii)&nbsp;and (iii) above, where such a conflict, breach,
violation or imposition would not reasonably be expected to have a Fund Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)&#8195;No holders of
securities of the Fund have rights to the registration of such securities under the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15)&#8195;The
financial statements, together with related schedules and notes, included or incorporated by reference in the Registration Statement and the Prospectus present fairly, in all material respects, the financial condition, results of operations and cash
flows of the Fund as of the dates and for the periods indicated, comply as to form with the applicable accounting requirements of the Securities Act and the Investment Company Act and have been prepared in conformity with generally accepted
accounting principles applied on a consistent basis throughout the periods involved (except as otherwise noted therein); and the other financial and statistical information and data included in the Registration Statement and the Prospectus are
accurately derived from such financial statements and the books and records of the Fund. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16)&#8195;No action, suit or
proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Fund or its property is pending or, to the knowledge of the Fund, threatened that (i)&nbsp;would reasonably be expected to have a material
adverse effect on the Fund&#8217;s performance of this Agreement or the consummation of any of the transactions herein contemplated or (ii)&nbsp;would reasonably be expected to have a Fund Material Adverse Effect, except as set forth in or
contemplated in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17)&#8195;The Fund owns or leases all such properties as
are necessary to the conduct of its operations as presently conducted. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18)&#8195;The Fund is not in violation or default of any provision of its
charter or bylaws or (i)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a party or bound or to which its
property is subject or (ii)&nbsp;any statute, law, rule, regulation, judgment, order or decree of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Fund or any of its
properties, except in the case of (i)&nbsp;and (ii) above, where such a violation or default would not reasonably be expected to have a Fund Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19)&#8195;Since the date as of which information is given in the Prospectus, except as otherwise stated therein,
(i)&nbsp;there has been no material adverse change in the condition (financial or otherwise), business prospects, earnings, business or properties of the Fund (other than as a result of a change in the financial markets generally), whether or not
arising from transactions in the ordinary course of business, (ii)&nbsp;there have been no transactions entered into by the Fund which are material to the Fund other than those in the ordinary course of its business as described in the Registration
Statement and the Prospectus and (iii)&nbsp;there has been no dividend or distribution of any kind declared, paid or made by the Fund on any class of its capital stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(20)&#8195;PricewaterhouseCoopers LLP, who have audited the financial statements of the Fund and delivered their report with
respect to the audited financial statements included or incorporated by reference in the Registration Statement and the Prospectus, is an independent registered public accounting firm with respect to the Fund within the meaning of the Securities
Act, the Investment Company Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(21)&#8195;The Fund has not distributed and, prior to the completion of the distribution
of the Placement Shares, will not distribute any offering material in connection with the offering and sale of the Placement Shares other than the Registration Statement, the Prospectus, any Additional Disclosure Item (as defined below) or other
materials filed by the Fund with the Commission pursuant to the Securities Act and/or the Investment Company Act, including Reports (as defined herein). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(22)&#8195;Without the prior consent of Jones (such consent not to be unreasonably withheld or delayed), the Fund has not made
and will not make any offer relating to the Placement Shares that would constitute a &#8220;free writing prospectus&#8221; as defined in Rule 405 under the Securities Act and which the parties agree, for the purposes of this Agreement, includes
(1)&nbsp;any &#8220;advertisement&#8221; as defined in Rule 482 under the Securities Act and treated by the Fund as subject to Rule 482 under the Securities Act and (2)&nbsp;any sales literature, materials or information provided to investors by, or
with the approval of, the Fund in connection with the sale or marketing of the offering of the Placement Shares, including any road show or investor presentations (including slides and scripts relating thereto) made to investors by or on behalf of
the Fund (the materials and information referred to in this <U>Section</U><U></U><U>&nbsp;6(a)(22)</U> are herein referred to as &#8220;<B><U>Additional Disclosure Items</U></B>&#8221;). All Additional Disclosure Items complied and will comply in
all material respects with (i)&nbsp;the applicable requirements of the Securities Act and the Investment Company Act, including without limitation all applicable filing (where required), legending and record keeping requirements, and (ii)&nbsp;the
rules and interpretations of FINRA. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(23)&#8195;The Fund is insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which it is engaged and which the Fund deems adequate; all policies of insurance insuring the Fund or its business, assets, employees,
officers and directors, including the Fund&#8217;s directors and officers errors and omissions insurance policy and its fidelity bond required by Rule <FONT STYLE="white-space:nowrap">17g-1</FONT> under the Investment Company Act, are in full force
and effect; the Fund is in compliance with the terms of such policy and fidelity bond in all material respects; and there are no claims by the Fund under any such policy or fidelity bond as to which any insurance company is denying liability or
defending under a reservation of rights clause; the Fund has not been refused any insurance coverage sought or applied for; and the Fund has no reason to believe that it will not be able to renew its existing insurance coverage and fidelity bond as
and when such coverage and fidelity bond expires or to obtain similar coverage and fidelity bond from similar insurers as may be necessary to continue its business at a cost that would not have a Fund Material Adverse Effect, except as set forth in
or contemplated in the Registration Statement and the Prospectus (exclusive of any supplement thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(24)&#8195;The
Fund possesses all licenses, certificates, permits and other authorizations issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct its business except to the extent that the failure to have any such permit
would not have a Fund Material Adverse Effect, except as set forth in or contemplated in the Registration Statement and the Prospectus (exclusive of any supplement thereto); the Fund has not received any notice of proceedings relating to the
revocation or modification of any such license, certificate, permit or authorization which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Fund Material Adverse Effect, except as set forth in
or contemplated in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(25)&#8195;The Fund maintains and will maintain a system
of internal accounting controls designed to provide reasonable assurances that (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific authorization and with the investment objectives, policies and restrictions
of the Fund and the applicable requirements of the Investment Company Act and the Internal Revenue Code of 1986, as amended (the &#8220;<B><U>Code</U></B>&#8221;); (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles, to calculate net asset value, to maintain accountability for assets and to maintain material compliance with the books and records requirements under the Investment Company Act;
(iii)&nbsp;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&nbsp;the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Fund employs &#8220;internal control over financial reporting&#8221; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">30a-3</FONT> under the Investment Company Act) and such
internal control over financial reporting is and shall be effective as required by the Investment Company Act. The Fund is not aware of any material weakness in its internal control over financial reporting. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(26)&#8195;The Fund maintains &#8220;disclosure controls and
procedures&#8221; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">30a-3</FONT> under the Investment Company Act); such disclosure controls and procedures are designed as required by the Investment Company Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(27)&#8195;The Fund has not taken, directly or indirectly, any action designed to or that would constitute or that might
reasonably be expected to cause or result in violation of federal securities laws, in stabilization or manipulation of the price of any security of the Fund to facilitate the offering and sale of the Placement Shares, and the Fund is not aware of
any such action taken or to be taken by any affiliates of the Fund other than (i)&nbsp;such actions as taken by Jones and (ii)&nbsp;tender offers, share repurchases and the issuance or purchase of shares pursuant to the Fund&#8217;s Dividend
Reinvestment Plan effected following the date on which the distribution of the Placement Shares is completed, in each case, so long as such actions are in compliance with all applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(28)&#8195;This Agreement and each of the Fund Agreements complies in all material respects with all applicable provisions of
the Securities Act, the Investment Company Act and the Advisers Act and the Fund&#8217;s directors and the Fund&#8217;s shareholders have approved the Management Agreement and the Subadvisory Agreements in accordance with Section&nbsp;15 of the
Investment Company Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(29)&#8195;Except as disclosed in the Registration Statement and the Prospectus, no director of
the Fund is an &#8220;interested person&#8221; (as defined in the Investment Company Act) of the Fund or an &#8220;affiliated person&#8221; (as defined in the Investment Company Act) of Jones. For purposes of this
<U>Section</U><U></U><U>&nbsp;6(a)(29)</U>, the Fund and the Manager shall be entitled to rely on representations from such officers and directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(30)&#8195;The Fund intends to direct the investment of the proceeds of the offering described in the Prospectus in such a
manner as to comply with the requirements of Subchapter M of the Code and intends to qualify as a regulated investment company under Subchapter M of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(31)&#8195;The conduct by the Fund of its business (as described in the Registration Statement and the Prospectus) does not
require it to be the owner, possessor or licensee of any patents, patent licenses, trademarks, service marks or trade names which it does not own, possess or license. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(32)&#8195;The Fund has filed all foreign, federal, state and local tax returns required to be filed or has properly requested
extensions thereof (except in any case in which the failure so to file would not have a Fund Material Adverse Effect, and except as set forth in or contemplated in the Registration Statement and the Prospectus) and has paid all taxes required to be
paid by it and any other assessment, fine or penalty levied against it, to the extent that any of the foregoing is due and payable, except for any such tax, assessment, fine or penalty that is currently being contested in good faith or as would not
have a Fund Material Adverse Effect, and except as set forth in or contemplated in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(33)&#8195;There is and has been no failure on the part of the Fund and any of the Fund&#8217;s directors or officers, in their
capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (the &#8220;<B><U>Sarbanes-Oxley Act</U></B>&#8221;). </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(34)&#8195;The Fund has adopted and implemented written policies and
procedures reasonably designed to prevent violation of the Federal Securities Laws (as that term is defined in Rule <FONT STYLE="white-space:nowrap">38a-1</FONT> under the Investment Company Act) by the Fund, including policies and procedures that
provide oversight of compliance by each investment adviser, administrator and transfer agent of the Fund. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(35)&#8195;The
operations of the Fund are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements and the money laundering statutes and the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;<B><U>Money Laundering Laws</U></B>&#8221;) and no action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Fund with respect to the Money Laundering Laws is pending or, to the knowledge of the Fund, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(36)&#8195;There are no business relationships or related-party transactions involving the Fund or any other person required to
be described in the Registration Statement and the Prospectus which have not been described as required, it being understood and agreed that the Fund and the Manager make no representation or warranty with respect to any such relationships involving
Jones or any affiliate and any other person that have not been disclosed to the Fund by Jones in connection with this offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(37)&#8195;Neither the Fund nor, to the knowledge of the Fund, any director, officer, agent, employee or affiliate of the Fund
is aware of or has taken any action in connection with the Fund, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended and the rules and regulations thereunder (the
&#8220;<B><U>FCPA</U></B>&#8221;) including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any
money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for
foreign political office, in contravention of the FCPA and the Fund, and to the knowledge of the Fund, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to
ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(38)&#8195;Neither the
Fund nor, to the knowledge of the Fund, any director, officer, agent, employee or affiliate of the Fund is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department
(&#8220;<B><U>OFAC</U></B>&#8221;); and the Fund will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for
the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any certificate signed by any officer of the Fund and delivered to Jones or counsel for
Jones in connection with the offering of the Placement Shares shall be deemed a representation and warranty by the Fund, as to matters covered therein, to Jones. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Representations and Warranties with Respect to the Manager.</U> The Manager represents and warrants to and agrees with Jones as
of the date hereof, as of each Representation Date (as defined in <U>Section</U><U></U><U>&nbsp;7(j)</U> below) and as of each Applicable Time as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&#8195;The Manager has been duly formed and is validly existing in good standing under the laws of the jurisdiction of its
organization, with full power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus, and is duly qualified to do business and is in good standing under the
laws of each jurisdiction which requires such qualification, except where the failure to so qualify does not have a material adverse change in the condition (financial or otherwise), business prospects, earnings, business or properties of the
Manager, whether or not arising from transactions in the ordinary course of business (a &#8220;<B><U>Manager Material Adverse Effect</U></B>&#8221;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&#8195;The Manager is duly registered as an investment adviser under the Advisers Act and the Manager is not prohibited by
the Advisers Act or the Investment Company Act from acting under the Management Agreement as contemplated by the Registration Statement and the Prospectus. The Manager has adopted and implemented written policies and procedures under Rule <FONT
STYLE="white-space:nowrap">206(4)-7</FONT> of the Advisers Act reasonably designed to prevent violation of the Advisers Act by the Manager and its supervised persons. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&#8195;The Manager has full limited liability company power and authority to enter into this Agreement, the Management
Agreement and the Subadvisory Agreement; the execution and delivery of, and the performance by the Manager of its obligations under, this Agreement, the Management Agreement and the Subadvisory Agreement have been duly authorized by the Manager; and
this Agreement, the Management Agreement and the Subadvisory Agreement have been duly executed and delivered by the Manager. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&#8195;The Manager has the financial resources available to it necessary for the performance of its services and obligations
as contemplated in the Registration Statement and the Prospectus and under this Agreement, the Management Agreement and the Subadvisory Agreement, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&#8195;The description of the Manager and its business, and the statements attributable to the Manager, in the Registration
Statement and the Prospectus complied and comply in all material respects with the provisions of the Securities Act, the Investment Company Act and the Advisers Act and did not and will not contain an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&#8195;No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Manager or its property is pending or, to the knowledge of the Manager, threatened that (i)&nbsp;is required to be described in the Registration Statement and the Prospectus that is not so described as required, (ii)&nbsp;would
</P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
reasonably be expected to have a material adverse effect on the ability of the Manager to fulfill its obligations hereunder or under the Management Agreement or the Subadvisory Agreement or
(iii)&nbsp;would reasonably be expected to have a Manager Material Adverse Effect, except as set forth in or contemplated in the Registration Statement and the Prospectus; and there are no agreements, contracts, indentures, leases, permits or other
instruments relating to the Manager that are required to be described in the Registration Statement or the Prospectus or to be filed as an exhibit to the Registration Statement that are not described or filed as required by the Securities Act and
the Investment Company Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&#8195;Since the date as of which information is given in the Prospectus, except as
otherwise stated therein, (i)&nbsp;there has been no material adverse change in the condition (financial or otherwise), business prospects, earnings, business or properties of the Manager, whether or not arising from transactions in the ordinary
course of business and (ii)&nbsp;there have been no transactions entered into by the Manager which are material to the Manager other than those in the ordinary course of its business as described in the Registration Statement and the Prospectus.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&#8195;The Manager possesses all licenses, certificates, permits and other authorizations issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct its business in the manner described in or contemplated in the Registration Statement and the Prospectus except to the extent that the failure to do so would not have a Manager
Material Adverse Effect; the Manager has not received any notice of proceedings relating to the revocation or modification of any such license, certificate, permit or authorization which, singly or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would have a Manager Material Adverse Effect, except as set forth in or contemplated in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&#8195;This Agreement, the Management Agreement and the Subadvisory Agreement comply in all material respects with all
applicable provisions of the Securities Act, the Investment Company Act and the Advisers Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&#8195;No consent,
approval, authorization, filing with or order of any court or governmental agency or body is required in connection with the transactions contemplated herein or in the Management Agreement or the Subadvisory Agreement except such as have been made
or obtained under the Securities Act, the Exchange Act, the Advisers Act, the Investment Company Act, the rules and regulations of FINRA, and such as may be required under the blue sky laws of any jurisdiction in connection with the purchase and
distribution of the Placement Shares in the manner contemplated herein and in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&#8195;Neither the execution, delivery or performance of this Agreement, the Management Agreement or the Subadvisory
Agreement nor the consummation of the transactions herein or therein contemplated, nor the fulfillment of the terms hereof or thereof, conflict with, result in a breach or violation of, or imposition of any lien, charge or encumbrance upon any
property or assets of the Manager pursuant to, (i)&nbsp;the organizational documents of the Manager, including without limitation, its articles of organization, certificate of formation or similar organizational documents and its operating
</P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
agreement, limited liability company agreement, membership agreement or other similar agreement, (ii)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement,
loan agreement or other agreement, obligation, condition, covenant or instrument to which the Manager is a party or bound or to which its property is subject or (iii)&nbsp;any statute, law, rule, regulation, judgment, order or decree applicable to
the Manager of any court, regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Manager or any of its properties, except in the case of (ii)&nbsp;and (iii) above, where such a conflict,
breach, violation or imposition would not have a Manager Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&#8195;The Manager has not taken,
directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in violation of federal securities laws, in stabilization or manipulation of the price of any security of the Fund to
facilitate the offering and sale of the Placement Shares, and the Manager is not aware of any such action taken or to be taken by any affiliates of the Manager, other than (i)&nbsp;such actions as taken by Jones and (ii)&nbsp;tender offers, share
repurchases and the issuance or purchase of shares pursuant to the Fund&#8217;s Dividend Reinvestment Plan effected following the date on which the distribution of the Placement Shares is completed, in each case, so long as such actions are in
compliance with all applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13)&#8195;In the event that the Fund, the Manager or any Subadviser makes available
any promotional materials related to the Placement Shares or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means,
the Manager will install and maintain or will cause to be installed and maintained, <FONT STYLE="white-space:nowrap">re-qualification</FONT> and password-protection or similar procedures which are reasonably designed to effectively prohibit access
to such promotional materials by persons other than registered broker-dealers and registered representatives thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)&#8195;The operations of the Manager and its subsidiaries are and have been conducted at all times in compliance with
applicable Money Laundering Laws and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Manager or any of its subsidiaries with respect to the Money Laundering Laws is
pending or, to the knowledge of the Manager, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15)&#8195;The Manager maintains a system of internal controls
designed to provide reasonable assurance that (i)&nbsp;transactions effectuated by it under the Management Agreement and the Subadvisory Agreement are executed in accordance with its management&#8217;s general or specific authorization; and
(ii)&nbsp;access to the Fund&#8217;s assets is permitted only in accordance with its management&#8217;s general or specific authorization. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16)&#8195;Neither the Manager nor, to the knowledge of the Manager, any director, officer, agent, employee or affiliate of the
Manager is aware of or has taken any action in connection with the Manager, directly or indirectly, that would result in a violation by such persons of the FCPA, including, without limitation, making use of the mails or any means or instrumentality
of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign
official&#8221; </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
(as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Manager, and to the
knowledge of the Manager, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued
compliance therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17)&#8195;Neither the Manager nor, to the knowledge of the Manager, any director, officer, agent,
employee or affiliate of the Manager is currently subject to any U.S. sanctions administered by OFAC; and the Manager will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to
any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any certificate signed by any officer of the Manager and delivered to Jones or counsel for Jones in connection with the offering of the
Placement Shares shall be deemed a representation and warranty by the Manager, as to matters covered therein, to Jones. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Representations and Warranties with Respect to the Subadviser and the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
Subadvisers.</U> The Subadviser represents and warrants to and agrees with Jones as of the date hereof, as of each Representation Date (as defined in <U>Section</U><U></U><U>&nbsp;7(j)</U> below) and as of each Applicable Time as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&#8195;Each Subadviser has been duly formed and is validly existing in good standing under the laws of the jurisdiction of
its organization, with full power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement and the Prospectus, and is duly qualified to do business and is in good standing under
the laws of each jurisdiction which requires such qualification, except where the failure to so register or qualify does not have a material adverse change in the condition (financial or otherwise), business prospects, earnings, business or
properties of such Subadviser, whether or not arising from transactions in the ordinary course of business ( a &#8220;<B><U>Subadviser Material Adverse Effect</U></B>&#8221;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&#8195;Each Subadviser is duly registered as an investment adviser under the Advisers Act and neither Subadviser is
prohibited by the Advisers Act or the Investment Company Act from acting under the Subadvisory Agreements as contemplated by the Registration Statement and the Prospectus. Each Subadviser has adopted and implemented written policies and procedures
under Rule <FONT STYLE="white-space:nowrap">206(4)-7</FONT> of the Advisers Act reasonably designed to prevent violation of the Advisers Act by each Subadviser and its supervised persons. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&#8195;The Subadviser has full power and authority to enter into this Agreement and each Subadvisory Agreement; each <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Subadviser has full power and authority to enter into its respective <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Subadvisory Agreement; the execution and delivery of, and the performance by the
Subadviser of its obligations under, this Agreement and the Subadvisory Agreements have been duly authorized by the Subadviser; the execution and delivery of, and the performance by each of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
Subadvisers of its obligations under, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Subadvisory Agreements have been duly authorized by each of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Subadvisers; and each <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Subadvisory Agreement has been duly executed and delivered by the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Subadvisers. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&#8195;Each Subadviser has the financial resources available to it
necessary for the performance of its services and obligations as contemplated in the Registration Statement and the Prospectus and under this Agreement and the Subadvisory Agreements, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&#8195;The description of each Subadviser and its business and the statements attributable to such Subadviser in the
Registration Statement and the Prospectus complied and comply in all material respects with the provisions of the Securities Act, the Investment Company Act and the Advisers Act and did not and will not contain an untrue statement of a material fact
or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&#8195;No action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving a Subadviser, or any of such Subadviser&#8217;s property is pending or, to the knowledge of the Subadviser, threatened that (i)&nbsp;is required to be described in the Registration Statement and the Prospectus that is not so described as
required, (ii)&nbsp;would reasonably be expected to have a material adverse effect on the ability of a Subadviser to fulfill its obligations hereunder or under the Subadvisory Agreements, as applicable or (iii)&nbsp;would reasonably be expected to
have a Subadviser Material Adverse Effect, except as set forth in or contemplated in the Registration Statement and the Prospectus; and there are no agreements, contracts, indentures, leases, permits or other instruments relating to the Subadvisers
that are required to be described in the Registration Statement or the Prospectus or to be filed as an exhibit to the Registration Statement that are not described or filed as required by the Securities Act or the Investment Company Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&#8195;Since the date as of which information is given in the Prospectus, except as otherwise stated therein, (i)&nbsp;there
has been no material adverse change in the condition (financial or otherwise), business prospects, earnings, business or properties of either Subadviser, whether or not arising from transactions in the ordinary course of business and (ii)&nbsp;there
have been no transactions entered into by either Subadviser which are material to such Subadviser other than those in the ordinary course of its business as described in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8)&#8195;Each Subadviser possesses all licenses, certificates, permits and other authorizations issued by the appropriate
federal, state or foreign regulatory authorities necessary to conduct such Subadviser&#8217;s business, in the manner described in or contemplated in the Registration Statement and the Prospectus except to the extent that the failure to do so would
not have a Subadviser Material Adverse Effect; neither Subadviser has received any notice of proceedings relating to the revocation or modification of any such license, certificate, permit or authorization which, singly or in the aggregate, if the
subject of an unfavorable decision, ruling or finding, would have a Subadviser Material Adverse Effect, except as set forth in or contemplated in the Registration Statement and the Prospectus. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9)&#8195;This Agreement, as it applies to each Subadviser, and each
Subadvisory Agreement comply in all material respects with all applicable provisions of the Securities Act, the Investment Company Act and the Advisers Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10)&#8195;No consent, approval, authorization, filing with or order of any court or governmental agency or body is required in
connection with the performance by a Subadviser under the Subadvisory Agreements, except such as have been made or obtained under the Securities Act, the Exchange Act, the Advisers Act, the Investment Company Act, the rules and regulations of FINRA,
and such as may be required under the blue sky laws of any jurisdiction in connection with the purchase and distribution of the Placement Shares in the manner contemplated herein and in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11)&#8195;Neither the execution, delivery or performance by a Subadviser of its obligations under this Agreement or the
Subadvisory Agreements nor the consummation of the transactions herein or therein contemplated, nor the fulfillment of the terms hereof or thereof, conflict with, result in a breach or violation of, or imposition of any lien, charge or encumbrance
upon any property or assets of the Subadvisers pursuant to, (i)&nbsp;the organizational documents of each Subadviser, including without limitation, its articles of organization, certificate of formation or similar organizational documents and its
operating agreement, limited liability company agreement, membership agreement or other similar agreement , (ii) the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which either Subadviser is a party or bound or to which its property is subject, or (iii)&nbsp;any statute, law, rule, regulation, judgment, order or decree applicable to either Subadviser of any court,
regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over such Subadviser or any of properties of such Subadviser, except in the case of (ii)&nbsp;and (iii) above, where such a conflict,
breach, violation or imposition would not have a Subadviser Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12)&#8195;Neither Subadviser has
taken, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in violation of federal securities laws, in stabilization or manipulation of the price of any security of the Fund
to facilitate the offering and sale of the Placement Shares, and neither Subadviser is aware of any such action taken or to be taken by any affiliates of such Subadviser, other than (i)&nbsp;such actions as taken by Jones and (ii)&nbsp;tender
offers, share repurchases and the issuance or purchase of shares pursuant to the Fund&#8217;s Dividend Reinvestment Plan effected following the date on which the distribution of the Placement Shares is completed, in each case, so long as such
actions are in compliance with all applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13)&#8195;The operations of the Subadvisers and subsidiaries of the
Subadvisers are and have been conducted at all times in compliance with applicable Money Laundering Laws and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Subadvisers,
or any of the affiliates or subsidiaries of the Subadvisers with respect to the Money Laundering Laws is pending or, to the knowledge of the Subadviser, threatened. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14)&#8195;Each Subadviser maintains a system of internal controls designed
to provide reasonable assurance that (i)&nbsp;transactions effectuated by it under the Subadvisory Agreements, as applicable, are executed in accordance with the general or specific authorization of the management of each Subadviser; and
(ii)&nbsp;access to the Fund&#8217;s assets is permitted only in accordance with the general or specific authorization of the management of each Subadviser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15)&#8195;Neither the Subadvisers nor, to the knowledge of the Subadviser, any director, officer, agent, employee or affiliate
of the Subadvisers is aware of or has taken any action in connection with the Subadvisers, directly or indirectly, that would result in a violation by such persons of the FCPA, including, without limitation, making use of the mails or any means or
instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any
&#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Subadvisers, and to the knowledge of the
Subadviser, the affiliates of the Subadvisers have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued
compliance therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16)&#8195;Neither the Subadvisers nor, to the knowledge of the Subadviser, any director, officer,
agent, employee or affiliate of the Subadvisers is currently subject to any U.S. sanctions administered by OFAC; and the Subadvisers will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any certificate signed by any officer of the Subadviser and delivered to Jones or counsel for Jones in connection with the offering of the
Placement Shares shall be deemed a representation and warranty by the Subadviser, as to matters covered therein, to Jones. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&#8195;<U>Covenants of the Fund and the Manager</U>. The Fund and the Manager, jointly and severally, covenant and agree with Jones that:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Fund will promptly advise Jones (i)&nbsp;when, during any period that a prospectus relating to the offer or sale of
Placement Shares is required to be delivered under the Securities Act, any amendment to the Registration Statement affecting the Placement Shares shall have become effective, (ii)&nbsp;of any request by the Commission for any amendment or supplement
to the Registration Statement, the Prospectus or any Additional Disclosure Items, or for any additional information, affecting or in respect of the Placement Shares, (iii)&nbsp;of the issuance by the Commission of any order suspending the
effectiveness of the Registration Statement affecting the Placement Shares or the institution or threatening of any proceeding for that purpose, and (iv)&nbsp;the receipt by the Fund of any notification with respect to the suspension of the
qualification of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose. The Fund will not file any amendment to the Registration Statement affecting the Placement Shares or any
supplement to the Prospectus affecting the Placement Shares unless the </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Fund has furnished Jones with a copy for its review prior to filing, and will not file any such proposed amendment or supplement affecting the Placement Shares to which Jones reasonably objects,
in any event until after the end of the period during which a prospectus is required to be delivered to purchasers of the Placement Shares under the Securities Act. Subject to the foregoing sentence, the Fund will cause the Prospectus Supplement to
be transmitted to the Commission for filing pursuant to Rule 424 under the Securities Act. The Fund will use its best efforts to prevent the issuance of any order suspending the effectiveness of the Registration Statement affecting the Placement
Shares and, if issued, to obtain as soon as possible the withdrawal thereof. The Fund will timely file the requisite copies of the Prospectus with the Commission pursuant to Rule 424(b) under the Securities Act and will advise Jones of the time and
manner of such filing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;During any period in which a Prospectus relating to the Placement Shares is required to be delivered by
Jones under the Securities Act with respect to a pending sale of the Placement Shares (whether physically or through compliance with Rule 153, Rule 172 or otherwise), the Fund will comply so far as it is able with all requirements imposed upon it by
the Securities Act, the Exchange Act and the Investment Company Act, as from time to time in force, so far as necessary to permit the continuance of sales of the Placement Shares during such period in accordance with the provisions hereof and the
Prospectus, and will file with the Commission and the Exchange all documents pursuant to the Securities Act, the Exchange Act and the Investment Company Act in the manner and within the time periods required by the Securities Act, Exchange Act and
the Investment Company Act. If during such period any event occurs as a result of which the Prospectus, as then amended or supplemented, or any Additional Disclosure Item would include an untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement, Prospectus or any Additional
Disclosure Item to comply with the Securities Act, the Fund will promptly notify Jones to suspend the offering of Placement Shares during such period and the Fund will promptly amend or supplement the Registration Statement, Prospectus or such
Additional Disclosure Item so as to correct such statement or omission or effect such compliance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&#8195;During any period in which
the Prospectus relating to the Placement Shares is required to be delivered by Jones under the Securities Act with respect to a pending sale of the Placement Shares (whether physically or through compliance with Rule 153, Rule 172 or otherwise), the
Fund will use its best efforts to cause the Placement Shares to be listed on the Exchange and to qualify, if necessary, the Placement Shares for sale under the securities laws of such United States jurisdictions as Jones reasonably designates and to
continue such qualifications in effect so long as required for the distribution of the Placement Shares; <U>provided</U>, <U>however</U>, that the Fund shall not be required in connection therewith to qualify as a foreign corporation or dealer in
securities, file a general consent to service of process in any jurisdiction, or meet any other requirement in connection with this <U>Section</U><U></U><U>&nbsp;7(c)</U> deemed by the Fund to be unduly burdensome. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&#8195;The Fund will make generally available to its security holders as soon as practicable, but in any event not later than 15 months
after the end of the Fund&#8217;s current fiscal quarter, an earnings statement covering a <FONT STYLE="white-space:nowrap">12-month</FONT> period that satisfies the provisions of Section&nbsp;11(a) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&#8195;The Fund agrees to pay all costs, fees and expenses incurred in connection with performance of its obligations hereunder and in
connection with the transactions </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contemplated under this Agreement, including, without limitation, (i)&nbsp;all expenses incident to the issuance and delivery of the Placement Shares (including all printing and engraving costs),
(ii) all fees and expenses of the registrar and transfer agent of the Placement Shares, (iii)&nbsp;all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Placement Shares, (iv)&nbsp;all reasonable fees
and expenses of the Fund&#8217;s counsel and the Fund&#8217;s independent public or certified public accountants and other advisors, (v)&nbsp;all costs and expenses incurred in connection with the preparation, printing, filing, shipping and
distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts) and the Prospectus, and all amendments and supplements thereto and this Agreement, (vi)&nbsp;all filing fees,
distribution fees, attorneys&#8217; fees and expenses incurred by the Fund in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Placement Shares for offer and sale
under the state securities or blue sky laws or any other country, including, if requested by Jones, the preparation by counsel for Jones and printing of a &#8220;Blue Sky Survey,&#8221; or other memorandum, and any supplements thereto, advising
Jones of such qualifications, registrations and exemptions, (vii)&nbsp;the fees and expenses associated with listing the Placement Shares on the Exchange, (viii)&nbsp;the filing fees incident to, and the reasonable fees and disbursements of counsel
to Jones in connection with, the review by FINRA of the terms of the sale of the Placement Shares (such fees and disbursements to be limited in accordance with clause (ix)&nbsp;below), (ix) the reasonable fees and expenses of counsel for Jones
(provided such fees and expenses (a)&nbsp;shall not exceed $40,000 in connection with the preparation and execution of this Agreement and the preparation and filing of the initial Prospectus Supplement dated as of the date hereof relating to the
Placement Shares and providing the services described in clauses (vi)&nbsp;and (viii) above and (b)&nbsp;shall not exceed $15,000 on an annual basis in each annual period following the date of this Agreement) and (x)&nbsp;all other fees, costs and
expenses incident to the performance by the Fund of its obligations hereunder. Except as provided in <U>Section</U><U></U><U>&nbsp;7(e)(ix)</U> above with respect to Jones (the &#8220;<B><U>Reimbursable Amounts</U></B>&#8221;), the aggregate amount
of any discount, commission or other compensation to be paid by the Fund to Jones in connection with Jones&#8217; performance of its obligations under this Agreement shall be as set forth on <U>Schedule 2</U> attached hereto. The Fund shall pay to
Jones the Reimbursable Amounts payable under this Section&nbsp;7 in addition to such discount, commissions and other compensation payable to Jones as contemplated by <U>Schedule 2</U>. Each of the Manager and the Subadviser agrees to pay all costs,
fees and expenses of its respective counsel, to the extent applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&#8195;The Fund will use the Net Proceeds as described in the
Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g)&#8195;The Fund will, at any time during the term of this Agreement, as supplemented from time to time, advise Jones
immediately after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to Jones pursuant
to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h)&#8195;The Fund will cooperate with any due diligence review conducted by Jones or its agents, including, without
limitation, providing information and making available documents and senior corporate officers, as Jones may reasonably request; <U>provided</U>, <U>however</U>, that the Fund shall be required to make available documents and senior corporate
officers only (i)&nbsp;at the Fund&#8217;s principal offices and (ii)&nbsp;during the Fund&#8217;s ordinary business hours. The parties acknowledge that the due diligence review contemplated by this <U>Section</U><U></U><U>&nbsp;7(h)</U> will
include during the term of this </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement a bring-down diligence conference among Jones and certain officers of the Fund&#8217;s operations or legal departments upon the issuance by the Fund of a Placement Notice and a
diligence conference to occur within five Business Days following the Fund&#8217;s filing of each of its annual report on Form <FONT STYLE="white-space:nowrap">N-CSR</FONT> (the &#8220;<B><U>Annual Report</U></B>&#8221;) and semi-annual report on <FONT
STYLE="white-space:nowrap">N-CSRS</FONT> (the &#8220;<B><U>Semi-Annual Report</U></B>&#8221;, together with the Annual Report (the &#8220;<B><U>Reports</U></B>&#8221;) whereby the Fund, the Manager and the Subadviser will make their respective
senior corporate officers, including portfolio managers, available to address certain diligence inquiries of Jones and will provide such additional information and documents as Jones may reasonably request. The requirement to conduct a due diligence
session under this <U>Section</U><U></U><U>&nbsp;7(h)</U> shall be waived if at the time such due diligence session is required pursuant to this Agreement there is no Placement Notice outstanding or the Fund has suspended the sale of, or otherwise
does not intend to sell, Placement Shares. Notwithstanding the foregoing, if the Fund subsequently decides to issue a Placement Notice or otherwise resume the sale of Placement Shares prior to the next occurring Representation Date, the Fund shall
conduct the due diligence session contemplated by this <U>Section</U><U></U><U>&nbsp;7(h)</U> at or prior to the issuance of such Placement Notice or the resumption of the sale of Placement Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&#8195;The Fund agrees that on such dates as the Securities Act shall require, the Fund will (i)&nbsp;file a Prospectus Supplement with
the Commission under Rule 424 under the Securities Act, which Prospectus Supplement will set forth, within the relevant period, the amount of Placement Shares sold through Jones, the Net Proceeds to the Fund and the compensation payable by the Fund
to Jones with respect to such Placement Shares, and (ii)&nbsp;deliver such number of copies of each such Prospectus Supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such
exchange or market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j)&#8195;During the term of this Agreement, each time the Fund (i)&nbsp;files the Prospectus relating to the
Placement Shares, (ii)&nbsp;amends or supplements the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement (other than a Prospectus Supplement filed in accordance
with <U>Section</U><U></U><U>&nbsp;7(i)</U> of this Agreement or a post-effective amendment solely to file this Agreement as an exhibit to the Registration Statement) or (iii)&nbsp;files a Report, each of the Fund, the Manager and the Subadviser
shall furnish Jones with a certificate, in the form attached hereto as <U>Exhibit 7(j)</U>. (Each date contemplated in subsections (i), (ii) and (iii)&nbsp;of this <U>Section</U><U></U><U>&nbsp;7(j)</U> is referred to herein as a
&#8220;<B><U>Representation Date</U></B>&#8221;). The requirement to provide a certificate under this <U>Section</U><U></U><U>&nbsp;7(j)</U> shall be waived if at the time of the required delivery of such certificate pursuant to this Agreement there
is no Placement Notice outstanding or the Fund has suspended the sale of, or otherwise does not intend to sell, Placement Shares. Notwithstanding the foregoing, if the Fund subsequently decides to issue a Placement Notice or otherwise resume the
sale of Placement Shares prior to the next occurring Representation Date, the Fund shall provide Jones with such certificate at or prior to the issuance of such Placement Notice or the resumption of the sale of Placement Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k)&#8195;Except as otherwise provided in the last sentence of this <U>Section</U><U></U><U>&nbsp;7(k)</U>, on the date hereof and thereafter
as of each Representation Date, or with respect to a Representation Date triggered by the filing of a Report, within three Business Days following the filing of such Report, the Fund shall cause to be furnished to Jones with a written opinion of
Simpson Thacher&nbsp;&amp; Bartlett LLP (the &#8220;<B><U>Fund Counsel</U></B>&#8221;)<B>, </B>dated the Representation Date or date of delivery, as applicable, in substantially the form attached hereto as <U>Exhibit 7(k)(i)(a)</U>, but modified, as
necessary, to relate to the Registration Statement and the Prospectus as then amended or </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#8195;supplemented; <U>provided</U>, <U>however</U>, that in lieu of such opinion, counsel may furnish Jones with a letter to the effect that Jones may rely on a prior opinion delivered under
this <U>Section</U><U></U><U>&nbsp;7(k)</U> to the same extent as if it were dated the date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or
supplemented at such Representation Date). Venable LLP or such other Maryland counsel that the Fund may select (in each case, &#8220;<B><U>Maryland Counsel</U></B>&#8221;) shall furnish a separate opinion as to matters relating specifically to or
otherwise governed by Maryland law, in substantially the form attached hereto as <U>Exhibit 7(k)(i)(b)</U>. In the event that a Representation Date is triggered by the filing of a Semi-Annual Report, only the opinion identified in <U>Exhibit
7(k)(ii)</U> shall be required and no opinion of Maryland Counsel shall be required. The requirement to provide the opinion of Fund Counsel and Maryland Counsel contemplated by this <U>Section</U><U></U><U>&nbsp;7(k)</U> shall be waived if at the
time of the required delivery of such opinion pursuant to this Agreement there is no Placement Notice outstanding or the Fund has suspended the sale of, or otherwise does not intend to sell, Placement Shares. Notwithstanding the foregoing, if the
Fund subsequently decides to issue a Placement Notice or otherwise resume the sale of Placement Shares prior to the next occurring Representation Date, the Fund shall provide Jones with such opinion of Fund Counsel and Maryland Counsel at or prior
to the issuance of such Placement Notice or the resumption of the sale of Placement Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; margin-right:1%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&#8195;(i)
Except as otherwise provided in the last sentence of this <U>Section</U><U></U><U>&nbsp;7(l)(i)</U>, on the date hereof and thereafter as of each Representation Date, or with respect to a Representation Date triggered by the filing of a Report,
within three Business Days following the filing of such Report, the Manager shall cause to be furnished to Jones a written opinion of <FONT STYLE="white-space:nowrap">in-house</FONT> counsel for the Manager (the &#8220;<B><U>Manager
Counsel</U></B>&#8221;)<B>, </B>dated the Representation Date, or date of delivery, as applicable in substantially the form attached hereto as <U>Exhibit 7(l)(i)</U>, but modified, as necessary, to relate to the Registration Statement and the
Prospectus as then amended or supplemented; <U>provided</U>, <U>however</U>, that in lieu of such opinion, counsel may furnish Jones with a letter to the effect that Jones may rely on a prior opinion delivered under this
<U>Section</U><U></U><U>&nbsp;7(l)(i)</U> to the same extent as if it were dated the date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or
supplemented at such Representation Date). In the event that a Representation Date is triggered by the filing of a Semi-Annual Report, the opinion contemplated in this <U>Section</U><U></U><U>&nbsp;7(l)(i)</U> shall not be required. The requirement
to provide the opinion of Manager Counsel contemplated by this <U>Section</U><U></U><U>&nbsp;7(l)(i)</U> shall be waived if at the time of the required delivery of such opinion pursuant to this Agreement there is no Placement Notice outstanding or
the Fund has suspended the sale of, or otherwise does not intend to sell, Placement Shares. Notwithstanding the foregoing, if the Fund subsequently decides to issue a Placement Notice or otherwise resume the sale of Placement Shares prior to the
next occurring Representation Date, the Fund shall provide Jones with such opinion of Manager Counsel at or prior to the issuance of such Placement Notice or the resumption of the sale of Placement Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&#8195;Except as otherwise provided in the last sentence of this <U>Section</U><U></U><U>&nbsp;7(l)(ii)</U>, on the date
hereof and thereafter as of each Representation Date, or with respect to a Representation Date triggered by the filing of a Report, within three Business Days following the filing of such Report, the Subadviser shall cause to be furnished to Jones
</P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
with a written opinion of <FONT STYLE="white-space:nowrap">in-house</FONT> counsel for the Subadviser (the &#8220;<B><U>Subadviser Counsel</U></B>&#8221;)<B>, </B>dated the Representation Date,
or date of delivery, as applicable, in substantially the form attached hereto as <U>Exhibit 7(l)(ii)</U>, but modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented; <U>provided</U>,
<U>however</U>, that in lieu of such opinion, counsel may furnish Jones with a letter to the effect that Jones may rely on a prior opinion delivered under this <U>Section</U><U></U><U>&nbsp;7(l)(ii)</U> to the same extent as if it were dated the
date of such letter (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented at such Representation Date). In the event that a Representation Date is
triggered by the filing of a Semi-Annual Report, the opinion contemplated in this <U>Section</U><U></U><U>&nbsp;7(l)(ii)</U> shall not be required. The requirement to provide the opinion of Subadviser Counsel contemplated by this
<U>Section</U><U></U><U>&nbsp;7(l)(ii)</U> shall be waived if at the time of the required delivery of such opinion pursuant to this Agreement there is no Placement Notice outstanding or the Fund has suspended the sale of, or otherwise does not
intend to sell, Placement Shares. Notwithstanding the foregoing, if the Fund subsequently decides to issue a Placement Notice or otherwise resume the sale of Placement Shares prior to the next occurring Representation Date, the Fund shall provide
Jones with such opinion of Subadviser Counsel at or prior to the issuance of such Placement Notice or the resumption of the sale of Placement Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)&#8195;On the date hereof and thereafter as of each Representation Date, or with respect to a Representation Date triggered by the filing
of a Report, within three Business Days following the filing of such Report, and, during any period in which the Prospectus relating to the Placement Shares is required to be delivered by Jones (whether physically or through compliance with Rule
153, Rule 172 or otherwise), each time that the Registration Statement is amended or the Prospectus supplemented to include additional amended financial information, Fund audited financial statements or Fund unaudited semi-annual financial
statements (in each case, a &#8220;<B><U>Financial Supplement</U></B>&#8221;) the Fund shall cause its independent accountants to furnish Jones letters (the &#8220;<B><U>Comfort Letters</U></B>&#8221;), dated the date of each applicable
Representation Date, or each date of delivery, as applicable, in form and substance satisfactory to Jones, (i)&nbsp;confirming that they are independent public accountants within the meaning of the Securities Act and are in compliance with the
applicable requirements relating to the qualification of accountants under Rule <FONT STYLE="white-space:nowrap">2-01</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Commission, (ii)&nbsp;stating, as of such date, the
conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings (the first such
letter, the &#8220;<B><U>Initial Comfort Letter</U></B>&#8221;) and (iii)&nbsp;updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as
necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter. Notwithstanding the foregoing, in the event that a Representation Date is triggered by the filing of the Fund&#8217;s
Semi-Annual Report, a Comfort Letter contemplated by this <U>Section</U><U></U><U>&nbsp;7(m)</U> shall not be required; <U>provided</U>, <U>however</U>, that in such case the Fund shall deliver to Jones on the applicable date of delivery with
respect to the filing of a Semi-Annual Report a certificate of the Fund&#8217;s principal financial officer substantially in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;7(m)</U> (the &#8220;<B><U>CFO Certificate</U></B>&#8221;). The
requirement to provide a Comfort Letter, or CFO Certificate, as applicable under this <U>Section</U><U></U><U>&nbsp;7(m)</U> shall be waived if at the time of the required delivery of the Comfort Letter or CFO Certificate pursuant to this Agreement
there is no Placement Notice outstanding or the Fund has suspended the sale of, or otherwise does </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not intend to sell, Placement Shares. Notwithstanding the foregoing, if the Fund subsequently decides to issue a Placement Notice or otherwise resume the sale of Placement Shares prior to the
next occurring applicable Report or Financial Supplement, the Fund shall provide Jones with a Comfort Letter or CFO Certificate, as applicable, at or prior to the issuance of such Placement Notice or the resumption of the sale of Placement Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n)&#8195;On the date hereof and thereafter as of each Representation Date, or with respect to a Representation Date triggered by the
filing of a Report, within three Business Days following the filing of such Report, each of the Fund, the Manager and the Subadviser shall furnish Jones with a certificate of its respective Secretary, in form and substance reasonably satisfactory to
Jones. The requirement to provide a certificate under this <U>Section</U><U></U><U>&nbsp;7(n)</U> shall be waived if at the time of the required delivery of such certificate pursuant to this Agreement there is no Placement Notice outstanding or the
Fund has suspended the sale of, or otherwise does not intend to sell, Placement Shares. Notwithstanding the foregoing, if the Fund subsequently decides to issue a Placement Notice or otherwise resume the sale of Placement Shares prior to the next
occurring Representation Date, the Fund shall provide Jones with such certificate at or prior to the issuance of such Placement Notice or the resumption of the sale of Placement Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o)&#8195;Each Placement Notice issued by the Fund to Jones shall be deemed to be an affirmation that the representations and warranties made
by it in this Agreement are true and correct in all material respects at the time such Placement Notice is issued, and that the Fund has complied in all material respects with all of the agreements to be performed by it hereunder at or prior to such
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p)&#8195;The Fund (including its agents and representatives, other than Jones in its capacity as such) will not make, use,
prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares
hereunder, except by means of the Registration Statement, the Prospectus or, upon Jones&#8217; prior written consent, such consent not to be unreasonably withheld or delayed, any Additional Disclosure Item. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q)&#8195;The Fund will comply with all requirements imposed upon it by the Securities Act, the Exchange Act and the Investment Company Act
as from time to time in force, so far as necessary to permit the continuance of sales of, or dealings in, the Placement Shares as contemplated by the provisions hereof and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(r)&#8195;The Fund will not, without giving Jones at least three Business Days prior written notice of a proposed sale, directly or
indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any shares of the Fund&#8217;s common stock (other than the Placement Shares offered pursuant to the provisions of this Agreement) or securities
convertible into or exchangeable for shares of the Fund&#8217;s common stock, warrants or any rights to purchase or acquire, shares of the Fund&#8217;s common stock during the period beginning on the fifth (5<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>) Trading Day immediately prior to the date on which any Placement Notice is delivered to Jones hereunder and ending on the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) Trading
Day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice; without the prior written consent of Jones, the Fund will not directly or indirectly engage in any other <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#8220;at-the-market&#8221;</FONT></FONT> or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise
</P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
dispose of any shares of the Fund&#8217;s common stock (other than the Placement Shares offered pursuant to the provisions of this Agreement) or securities convertible into or exchangeable for
shares of the Fund&#8217;s common stock, warrants or any rights to purchase or acquire, shares of the Fund&#8217;s common stock prior to the tenth (10<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) Trading Day immediately following the
final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice; <U>provided</U>, <U>however</U>, that such restrictions will not be required in connection with the Fund&#8217;s issuance or sale of shares of the
Fund&#8217;s common stock pursuant to (i)&nbsp;the Dividend Reinvestment Plan, and<B> </B>(ii)&nbsp;conversion of securities or the exercise of warrants, options or other rights in effect or outstanding as of the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(s)&#8195;The Fund will furnish to Jones and its counsel (at the expense of the Fund) copies of the Registration Statement, the Prospectus,
any Additional Disclosure Item and all amendments and supplements thereto relating to the registration and issuance of the Placement Shares pursuant to this Agreement that are filed with the Commission during the period in which a prospectus
relating to the Placement Shares is required to be delivered under the Securities Act (whether physically or through compliance with Rule 153, Rule 172 or otherwise), in each case as soon as reasonably practicable and in such quantities as Jones may
from time to time reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(t)&#8195;Each of the Fund, the Manager and the Subadviser acknowledges and agrees that Jones has
informed the Fund that Jones may, to the extent permitted under the Securities Act, the Exchange Act and the Investment Company Act, purchase and sell Placement Shares for its own account at the same time as Placement Shares are being sold by the
Fund pursuant to this Agreement, provided that (i)&nbsp;the Fund shall not be deemed to have authorized or consented to any such purchases or sales by Jones and (ii)&nbsp;no such purchases or sales shall take place while a Placement Notice is in
effect (except to the extent Jones may engage in sales of Placement Shares (A)&nbsp;purchased or deemed purchased from the Fund as a &#8220;riskless principal&#8221; or in a similar capacity or (B)&nbsp;with respect to errors that cause Jones to
take an unplanned principal positions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(u)&#8195;The Fund will not, directly or indirectly, (i)&nbsp;take any action designed to cause
or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Fund to facilitate the sale or resale of the Placement Shares or (ii)&nbsp;sell, bid for, or
purchase the Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement Shares other than Jones; <B><U>provided</U></B>, <B><U>however</U></B>, the Fund may issue and sell shares of the Fund&#8217;s common stock
pursuant to the Dividend Reinvestment Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&#8195;The Fund, the Manager and the Subadviser will furnish to Jones for a period of two
years from the date of this Agreement such information as reasonably requested by Jones regarding the Fund, the Manager or the Subadviser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&#8195;<U>Conditions to Jones</U><U>&#8217;</U><U>s Obligations</U>. The obligations of Jones hereunder with respect to a Placement will be
subject to the continuing accuracy and completeness of the representations and warranties made by the Fund, the Manager and the Subadviser herein, to the due performance by the Fund, the Manager and the Subadviser of their respective obligations
hereunder, to the completion by Jones of a due diligence review satisfactory to Jones in its reasonable judgment, and to the continuing satisfaction (or waiver by Jones in its sole discretion) of the following additional conditions: </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;The Registration Statement shall have become effective and shall be available for
the sale of (i)&nbsp;all Placement Shares issued pursuant to all prior Placements and not yet sold by Jones and (ii)&nbsp;all Placement Shares contemplated to be issued by the Placement Notice relating to such Placement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;None of the following events shall have occurred and be continuing: (i)&nbsp;receipt by the Fund of any request for additional
information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any amendments or supplements to the Registration Statement,
the Prospectus or any Additional Disclosure Item relating to or affecting the Placement Shares; (ii)&nbsp;the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the
Registration Statement or the initiation of any proceedings for that purpose, including any notice objecting to the use of the Registration Statement or order pursuant to <U>Section</U><U></U><U>&nbsp;8(e)</U> of the Investment Company Act having
been issued and proceedings therefor initiated, or to the knowledge of the Fund, threatened by the Commission; (iii)&nbsp;receipt by the Fund of any notification with respect to the suspension of the qualification or exemption from qualification of
any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; (iv)&nbsp;the occurrence of any event that makes any statement made in the Registration Statement, the Prospectus or any
Additional Disclosure Item untrue in any material respect or that requires the making of any changes in the Registration Statement, Prospectus or such Additional Disclosure Item so that, in the case of the Registration Statement, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus or any Additional Disclosure Item, it will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and
(v)&nbsp;the Fund&#8217;s reasonable determination that a post-effective amendment to the Registration Statement would be appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Jones shall not have advised the Fund that the Registration Statement, Prospectus or any Additional Disclosure Item, or any
amendment or supplement thereto, contains an untrue statement of a material fact regarding Jones that in Jones&#8217; opinion is material, or omits to state a fact regarding Jones that in Jones&#8217; opinion is material and is required to be stated
therein or is necessary to make the statements therein, in light of the circumstances under which it was made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&#8195;Except as contemplated or disclosed in the Prospectus, there shall not have been any material change, on a consolidated basis, in
the authorized capital stock of the Fund or any Fund Material Adverse Effect, Manager Material Adverse Effect or Subadviser Material Adverse Effect, or any development that may reasonably be expected to cause a Fund Material Adverse Effect, Manager
Material Adverse Effect or Subadviser Material Adverse Effect or a downgrading in or withdrawal of the rating assigned to any of the Fund&#8217;s securities by any rating organization or a public announcement by any rating organization that it has
under surveillance or review its rating of any of the Fund&#8217;s securities, the effect of which, in the case of any such action by a rating organization described above, in the sole judgment of Jones (without relieving the Fund of any obligation
or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&#8195;Jones shall have received the opinions of Fund Counsel and Maryland Counsel
required to be delivered pursuant <U>Section</U><U></U><U>&nbsp;7(k)</U> on or before the date on which such delivery of such opinion is required pursuant to <U>Section</U><U></U><U>&nbsp;7(k)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&#8195;Jones shall have received the opinions of Manager Counsel and Subadviser Counsel required to be delivered pursuant
<U>Section</U><U></U><U>&nbsp;7(l)</U> on or before the date on which such delivery of such opinions are required pursuant to <U>Section</U><U></U><U>&nbsp;7(l)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g)&#8195;Jones shall have received the Comfort Letter, and to the extent applicable, the CFO Certificate, required to be delivered pursuant
<U>Section</U><U></U><U>&nbsp;7(m)</U> on or before the date on which such delivery of such Comfort Letter or CFO Certificate is required pursuant to <U>Section</U><U></U><U>&nbsp;7(m)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h)&#8195;Jones shall have received the certificates required to be delivered pursuant to <U>Section</U><U></U><U>&nbsp;7(j)</U> and
<U>Section</U><U></U><U>&nbsp;7(n)</U> on or before the date on which delivery of such certificate is required pursuant to <U>Section</U><U></U><U>&nbsp;7(j)</U> and <U>Section</U><U></U><U>&nbsp;7(n)</U>, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&#8195;Trading in the shares of the Fund&#8217;s common stock shall not have been suspended on the Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j)&#8195;On each date on which the Fund is required to deliver a certificate pursuant to <U>Section</U><U></U><U>&nbsp;7(j)</U>, the Fund
shall have furnished to Jones such appropriate further information, certificates and documents as Jones may reasonably request. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof. The Fund
will furnish Jones with such conformed copies of such opinions, certificates, letters and other documents as Jones shall reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k)&#8195;All filings with the Commission required by Rule 424 or Rule 497, as applicable, under the Securities Act to have been filed prior
to the giving of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424 or Rule 497, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l)&#8195;The Placement Shares shall have been approved for listing on the Exchange, subject only to notice of issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m)&#8195;There shall not have occurred any event that would permit Jones to terminate this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;11(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n)&#8195;Prior to the date hereof, FINRA shall have confirmed that it has no objection with
respect to the fairness and reasonableness of the placement terms and arrangements set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&#8195;<U>Indemnification and
Contribution</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Indemnification by the Fund and the Manager</U>. The Fund and the Manager, jointly and severally, agree
to indemnify and hold harmless Jones, its directors, members, officers and each person, if any, who controls Jones within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act as follows: </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&#8195;against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto) including any information deemed to be a part thereof pursuant to Rule
430B or 430C or Rule 424 under the Securities Act, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or
alleged untrue statement of a material fact included in any Additional Disclosure Item, any Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&#8195;against any
and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened,
or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to <U>Section</U><U></U><U>&nbsp;9(e)</U> below) any such settlement is effected with the written
consent of the Fund and the Manager; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&#8195;against any and all expense whatsoever, as incurred (including the fees
and disbursements of counsel chosen by Jones), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim
whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (1)&nbsp;or (2) above, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent
arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Fund or the Manager by Jones expressly for use in the Registration Statement
(or any amendment thereto), any Additional Disclosure Item, or in any Prospectus (or any amendment or supplement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Indemnification by Jones</U>. Jones agrees to indemnify and hold harmless each of the Fund and the Manager, each of their
directors, trustees, members, each of their officers who signed the Registration Statement, and each person, if any, who controls the Fund or the Manager within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange
Act against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection <U>(a)</U>&nbsp;of this <U>Section</U><U></U><U>&nbsp;9</U>, as incurred, but only with respect to any untrue statements or
omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto), any Additional Disclosure Item, or any Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with
written information furnished to the Fund or the Manager by Jones expressly for use in the Registration Statement (or any amendment thereto), any Additional Disclosure Item, or any Prospectus (or any amendment or supplement thereto). The Fund and
the Manager acknowledge that Jones has not furnished any information to the Fund for inclusion in the Prospectus. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&#8195;<U>Actions against Parties; Notification</U>. Each indemnified party shall give
notice as promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying
party from any liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. Counsel to the
indemnified parties shall be selected as follows: counsel to Jones, its directors, members, officers, and each person, if any, who controls Jones within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act
shall be selected by Jones; counsel to the Fund, its directors, trustees, members, each of its officers who signed the Registration Statement and each person, if any, who controls the Fund within the meaning of Section&nbsp;15 of the Securities Act
or Section&nbsp;20 of the Exchange Act shall be selected by the Fund; and counsel to the Manager and each person, if any, who controls the Manager within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act
shall be selected by the Manager. An indemnifying party may participate at its own expense in the defense of any such action; <U>provided</U>, <U>however</U>, that counsel to the indemnifying party shall not (except with the consent of the
indemnified party) also be counsel to the indemnified party. In no event shall the indemnifying parties be liable for the fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for Jones, its
directors, members, officers and each person, if any, who controls Jones within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, the fees and expenses of more than one counsel (in addition to any local
counsel) separate from their own counsel for the Fund, each of their directors, trustees, members, each of its officers who signed the Registration Statement and each person, if any, who controls the Fund within the meaning of Section&nbsp;15 of the
Securities Act or Section&nbsp;20 of the Exchange Act, the fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for the Manager, and the fees and expenses of more than one counsel, in each
case in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written consent of the
indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of
which indemnification or contribution could be sought under this <U>Section</U><U></U><U>&nbsp;9</U> hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent
(i)&nbsp;includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a
failure to act by or on behalf of any indemnified party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&#8195;<U>Settlement Without Consent if Failure to Reimburse</U>. If at any
time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by
<U>Section</U><U></U><U>&nbsp;9(a)(2)</U> effected without its written consent if (i)&nbsp;such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii)&nbsp;such indemnifying party shall
have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the
date of such settlement. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&#8195;<U>Other Agreements with Respect to Indemnification and Contribution</U>. The
provisions of this <U>Section</U><U></U><U>&nbsp;9</U> hereof shall not affect any agreements among the Fund and the Manager with respect to indemnification of each other or contribution between themselves. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f)&#8195;<U>Contribution</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&#8195;If the indemnification provided for in this <U>Section</U><U></U><U>&nbsp;9</U> hereof is for any reason unavailable
to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities,
claims, damages and expenses incurred by such indemnified party, as incurred, (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Fund and the Manager on the one hand and Jones on the other hand from the
offering of the Placement Shares pursuant to this Agreement or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause (i)&nbsp;above but also the relative fault of the Fund and the Manager on the one hand and of Jones on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as
well as any other relevant equitable considerations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2)&#8195;The relative benefits received by the Fund and the Manager
on the one hand and Jones on the other hand in connection with the offering of the Placement Shares pursuant to this Agreement shall be deemed to be in the same respective proportions as the Net Proceeds from the offering of the Placement Shares
pursuant to this Agreement (before deducting expenses) received by the Fund and the Manager and the total discounts and commissions received by Jones as calculated in accordance with the terms set forth in <U>Schedule 2</U>, bear to the aggregate
gross proceeds from the sale of Placement Shares pursuant to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)&#8195;The relative fault of the Fund and
the Manager on the one hand and Jones on the other hand shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates
to information supplied by the Fund, by the Manager, or by Jones and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&#8195;The Fund, the Manager, and Jones agree that it would not be just and equitable if contribution pursuant to this
<U>Section</U><U></U><U>&nbsp;9(f)</U> were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this <U>Section</U><U></U><U>&nbsp;9(f)</U>. The
aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this <U>Section</U><U></U><U>&nbsp;9(f)</U> shall be deemed to include any legal or other expenses reasonably incurred by
such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged
untrue statement or omission or alleged omission. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&#8195;Notwithstanding the provisions of this
<U>Section</U><U></U><U>&nbsp;9(f)</U>, Jones shall not be required to contribute any amount in excess of the amount by which the total price of the Placement Shares actually distributed by Jones exceeds the amount of any damages that Jones has
otherwise been required to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6)&#8195;No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7)&#8195;For
purposes of this <U>Section</U><U></U><U>&nbsp;9(f)</U>, each person, if any, who controls Jones within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act shall have the same rights to contributions as Jones,
and each person who controls the Fund or the Manager within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, each officer of the Fund and the Manager and each trustee, director or member of the Fund and
the Manager shall have the same rights to contribution as the Fund and the Manager. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g)&#8195;The indemnity and contribution agreements
contained in this <U>Section</U><U></U><U>&nbsp;9</U> and the representation and warranties of the Fund and the Manager set forth in this Agreement shall remain operative and in full force and effect, regardless of (i)&nbsp;any investigation made by
or on behalf of Jones, its partners, officers or employees, or any person controlling Jones, within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and or by or on behalf of the Fund and/or the Manager,
its directors and officers or any person who controls the Fund, and/or the Manager within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, (ii)&nbsp;delivery and acceptance of the Placement Shares and
payment therefor, or (iii)&nbsp;any termination of this Agreement. A successor to Jones or to the Fund or the Manager, its respective directors or officers, or any person controlling the Fund, or the Manager, shall be entitled to the benefits of the
indemnity, contribution and reimbursement agreements contained in this <U>Section</U><U></U><U>&nbsp;9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&#8195;<U>Representations
and Agreements to Survive Delivery</U>. All representations and warranties of the Fund and the Manager herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i)&nbsp;any investigation made by
or on behalf of Jones, any controlling persons, or the Fund and/or the Manager (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii)&nbsp;any
termination of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&#8195;<U>Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;Jones shall have the right by giving notice as hereinafter specified at any time to terminate this Agreement if (i)&nbsp;any Fund
Material Adverse Effect, Manager Material Adverse Effect or Subadviser Material Adverse Effect has occurred which, in the reasonable judgment of Jones, may materially impair the investment quality of the Placement Shares, (ii)&nbsp;the Fund, the
Manager or the Subadviser shall have failed, refused or been unable to perform any </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreement on its part to be performed hereunder; <U>provided</U>, <U>however</U>, in the case of any failure of the Fund, the Manager or the Subadviser to deliver (or cause another person to
deliver) any certification, opinion, or letter required under <U>Sections 7(j)</U>, <U>7(k)</U>,<U> 7(l)</U> or <U>7(m)</U> Jones&#8217;s right to terminate shall not arise unless such failure to deliver (or cause to be delivered) continues for more
than thirty (30)&nbsp;days from the date of such Representation Date pursuant to which such delivery was required; <U>provided</U>, <U>further</U>, <U>that</U>, Jones shall have the right to suspend its obligations hereunder, regardless of whether a
Placement Notice is pending, beginning on the sixth (6<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) day after the date of any Representation Date if any certification, opinion, or letter referenced in the foregoing proviso has not yet
been (or caused to be) delivered; (iii)&nbsp;any other condition of Jones&#8217;s obligations hereunder is not fulfilled, or (iv)&nbsp;any suspension or limitation of trading in the Placement Shares or in securities generally on the Exchange shall
have occurred. Any such termination shall be without liability of any party to any other party except that the provisions of <U>Section</U><U></U><U>&nbsp;7(e)</U>, <U>Section</U><U></U><U>&nbsp;9</U>, <U>Section</U><U></U><U>&nbsp;10</U>,
<U>Section</U><U></U><U>&nbsp;15</U>, <U>Section</U><U></U><U>&nbsp;17</U> and <U>Section</U><U></U><U>&nbsp;19</U> hereof shall remain in full force and effect notwithstanding such termination. If Jones elects to terminate this Agreement as
provided in this <U>Section</U><U></U><U>&nbsp;11</U>, Jones shall provide the required notice as specified herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;The Fund
shall have the right, by giving notice as hereinafter specified to terminate this Agreement in its sole discretion at any time. Any such termination shall be without liability of any party to any other party except that the provisions of
<U>Section</U><U></U><U>&nbsp;7(e)</U>, <U>Section</U><U></U><U>&nbsp;9</U>, <U>Section</U><U></U><U>&nbsp;10</U>, <U>Section</U><U></U><U>&nbsp;15</U>, <U>Section</U><U></U><U>&nbsp;17</U> and <U>Section</U><U></U><U>&nbsp;19</U> hereof shall
remain in full force and effect notwithstanding such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&#8195;Jones shall have the right, by giving notice as hereinafter
specified to terminate this Agreement in its sole discretion<B> </B>at any time. Any such termination shall be without liability of any party to any other party except that the provisions of <U>Section</U><U></U><U>&nbsp;7(e)</U>,
<U>Section</U><U></U><U>&nbsp;9</U>, <U>Section</U><U></U><U>&nbsp;10</U>, <U>Section</U><U></U><U>&nbsp;15</U>, <U>Section</U><U></U><U>&nbsp;17</U> and <U>Section</U><U></U><U>&nbsp;19</U> hereof shall remain in full force and effect
notwithstanding such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&#8195;This Agreement shall remain in full force and effect unless terminated pursuant to
<U>Sections 11(a)</U>, <U>(b)</U> or <U>(c)</U>&nbsp;above or otherwise by mutual agreement of the parties; <U>provided</U>, <U>however</U>, that any such termination by mutual agreement shall in all cases be deemed to provide that
<U>Section</U><U></U><U>&nbsp;7(e)</U>, <U>Section</U><U></U><U>&nbsp;9</U>, <U>Section</U><U></U><U>&nbsp;10</U>, <U>Section</U><U></U><U>&nbsp;15</U>, <U>Section</U><U></U><U>&nbsp;17</U> and <U>Section</U><U></U><U>&nbsp;19</U> shall remain in
full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e)&#8195;Except as otherwise provided in <U>Sections 11(b)</U> and <U>11(c)</U>, any termination of this
Agreement shall be effective on the date specified in such notice of termination; <U>provided</U>, <U>however</U>, that such termination shall not be effective until the close of business on the date of receipt of such notice by Jones or the Fund or
the Manager, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&#8195;<U>Notices</U>. All notices or other communications required or permitted to be given by any party to any other party pursuant to
the terms of this Agreement shall be in writing and if sent to Jones, shall be delivered to Jones at JonesTrading Institutional Services LLC, 900 Island Park Drive, Suite 200, Charleston, South Carolina 29492, Attention: Burke Cook, <FONT
STYLE="white-space:nowrap">e-mail</FONT> (burke@jonestrading.com), and Troutman Pepper Locke LLP, 1001 Haxall Point, Richmond, Virginia 23219, Attention: Michael T. Damgard, fax no. (804) <FONT STYLE="white-space:nowrap">698-5185,</FONT> <FONT
STYLE="white-space:nowrap">e-mail</FONT> (teddy.damgard@troutman.com); or if sent to the Fund, the Manager or the Subadviser, shall be </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivered to the Secretary of the Fund at 100 First Stamford Place, 6<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor, Stamford, CT 06902 Attention: Marc A. De Oliveira, <FONT
STYLE="white-space:nowrap">e-mail</FONT> (marc.deoliveira@franklintempleton.com), with a copy to Simpson Thacher&nbsp;&amp; Bartlett LLP, 900 G Street NW, Washington, DC 20001, Attention: David Blass and Ryan Brizek, fax no: (202) <FONT
STYLE="white-space:nowrap">636-5502,</FONT> <FONT STYLE="white-space:nowrap">e-mail</FONT> (david.blass@stblaw.com; ryan.brizek@stblaw.com). Each party to this Agreement may change such address for notices by sending to the parties to this Agreement
written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i)&nbsp;when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before 4:30 p.m., New York
City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii)&nbsp;on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii)&nbsp;on the Business<B> </B>Day
actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#8220;<B><U>Business Day</U></B>&#8221; shall mean any day on which the Exchange and
commercial banks in the City of New York are open for business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&#8195;<U>Successors</U>. This Agreement shall inure to the benefit of
and be binding upon Jones, the Fund, the Manager and the Subadviser and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than Jones, the
Fund, the Manager and the Subadviser and their respective successors and the controlling persons and directors, officers, members and trustees referred to in <U>Section</U><U></U><U>&nbsp;9</U> and their heirs and legal representatives, any legal or
equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of Jones, the Fund, the Manager
and the Subadviser and their respective successors, and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Placement Shares from
Jones shall be deemed to be a successor by reason merely of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&#8195;<U>Partial Unenforceability</U>. The invalidity or
unenforceability of any Section, paragraph or provision of this Agreement shall not affect the validity or enforceability of any other Section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason
determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as are necessary to make it valid and enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&#8195;<U>Governing Law Provisions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&#8195;<U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the internal laws of the state of New
York applicable to agreements made and to be performed in such state. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&#8195;<U>Consent to Jurisdiction</U>. Any legal suit, action
or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby may be instituted in the federal or state courts of the United States of America located in the Southern District of New York and borough of Manhattan
(collectively, the &#8220;<B><U>Specified Courts</U></B>&#8221;), and each party irrevocably submits to the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a judgment of any such court, as to which such
jurisdiction is <FONT STYLE="white-space:nowrap">non-exclusive)</FONT> of such courts in any such suit, action or proceeding. Service of any process, summons, notice or document by mail to such party&#8217;s address set forth above shall be
effective service of process for any suit, action or </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other proceeding brought in any such court. The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts
and irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&#8195;<U>General Provisions</U>. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior
written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof, including without limitation, the Original Agreement. This Agreement may be executed in two or more counterparts,
each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein
(express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. The Section headings, titled and captions herein are for the convenience of the parties only and shall not affect the construction or
interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&#8195;<U>Waiver of Jury Trial</U>. The Fund, the Manager, the Subadviser and Jones each hereby
irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this Agreement or any transaction contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&#8195;<U>Adjustments for Stock Splits</U>. The parties acknowledge and agree that all share related numbers contained in this Agreement
shall be adjusted to take into account any stock split, stock dividend or similar event effected with respect to shares of the Fund&#8217;s common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&#8195;<U>Absence of Fiduciary Relationship</U>. The Fund, the Manager and the Subadviser acknowledge that in connection with the offering
of the Placement Shares: (a)&nbsp;Jones has acted at arm&#8217;s length and owes no fiduciary duties to, the Fund, the Manager and the Subadviser or any other person; (b)&nbsp;Jones owes the Fund, the Manager and the Subadviser only those duties and
obligations set forth in this Agreement and prior or contemporaneous written agreements (to the extent not superseded by this Agreement), if any, and (iii)&nbsp;Jones may have interests that differ from those of the Fund, the Manager and the
Subadviser. The Fund, the Manager and the Subadviser waive to the full extent permitted by applicable law any claims any of them may have against Jones arising from an alleged breach of fiduciary duty in connection with the offering of the Placement
Shares as contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Remainder of Page Intentionally Blank] </B></P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the understanding between the Fund, the Manager, the
Subadviser and Jones, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Fund, the Manager, the Subadviser and Jones. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>WESTERN ASSET HIGH INCOME FUND II INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>FRANKLIN TEMPLETON FUND ADVISER, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>WESTERN ASSET MANAGEMENT COMPANY, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACCEPTED as of the date first-above written:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>JONESTRADING INSTITUTIONAL SERVICES LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV>
</DIV>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)(2)
<SEQUENCE>3
<FILENAME>d879285dex99l2.htm
<DESCRIPTION>EX-99.(L)(2)
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.(l)(2)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g879285g0925061745048.jpg" ALT="LOGO" STYLE="width:2.23056in;height:0.497917in;">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">750 E. PRATT STREET SUITE 900 BALTIMORE, MD 21202<B></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>T</B> 410.244.7400 <B>F</B> 410.244.7742 www.Venable.com</P></TD></TR>
</TABLE> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">September&nbsp;26, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Western Asset High
Income Fund II Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Madison Avenue, 17th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New
York, New York 10010 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Registration Statement on Form <FONT STYLE="white-space:nowrap">N-2:</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1933 Act File No.: <FONT STYLE="white-space:nowrap">333-285996</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><U>1940 Act File No.: <FONT STYLE="white-space:nowrap">811-08709</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have served as
Maryland counsel to Western Asset High Income Fund II Inc., a Maryland corporation registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;), as a <FONT STYLE="white-space:nowrap">closed-end</FONT> management
investment company (the &#8220;Company&#8221;), in connection with certain matters of Maryland law arising out of the issuance of shares (the &#8220;Shares&#8221;) of common stock, $0.001 par value per share (the &#8220;Common Stock&#8221;), of the
Company having an aggregate sales price of up to $185,000,000 covered by the above-referenced Registration Statement, and all amendments thereto (the &#8220;Registration Statement&#8221;), filed by the Company with the United States Securities and
Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;), and the 1940 Act. The Shares are to be issued from time to time in public offerings at market or negotiated prices pursuant
to a Prospectus Supplement, dated September&nbsp;26, 2025 (the &#8220;Prospectus Supplement&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with our
representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (collectively, the &#8220;Documents&#8221;):
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. The Registration Statement and the related form of prospectus included therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. The Prospectus Supplement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. The charter of the Company (the &#8220;Charter&#8221;), certified by the State Department of Assessments and Taxation of Maryland (the
&#8220;SDAT&#8221;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. The Fourth Amended and Restated Bylaws of the Company, certified as of the date hereof by an officer of the
Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. A certificate of the SDAT as to the good standing of the Company, dated as of a recent date; </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g879285g0925061745048.jpg" ALT="LOGO" STYLE="width:2.23056in;height:0.497917in;">
 </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Western Asset High Income Fund II Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;26, 2025
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. Resolutions (the &#8220;Resolutions&#8221;) adopted by the Board of Directors of the
Company, and a duly authorized committee thereof, relating to the registration and issuance of the Shares, certified as of the date hereof by an officer of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. A certificate executed by an officer of the Company, dated as of the date hereof; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. Such other documents and matters as we have deemed necessary or appropriate to express the opinion set forth below, subject to the
assumptions, limitations and qualifications stated herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In expressing the opinion set forth below, we have assumed the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. Each individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. Each individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. Each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the
Documents to which such party is a signatory, and such party&#8217;s obligations set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not
differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted to us as certified or photostatic copies conform to the original documents. All signatures on all such
Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents are true and complete. There has been no oral or
written modification of or amendment to any of the Documents, and there has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. Upon any issuance of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of
shares of Common Stock that the Company is then authorized to issue under the Charter. </P>
</DIV>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<DIV STYLE="width:8.5in" align="left">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g879285g0925061745048.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Western Asset High Income Fund II Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">September&nbsp;26, 2025
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the assumptions, limitations and qualifications
stated herein, it is our opinion that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. The Company is a corporation duly incorporated and existing under and by virtue of the laws of
the State of Maryland and is in good standing with the SDAT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. The issuance of the Shares has been duly authorized and, when issued and
delivered by the Company pursuant to the Resolutions and the Registration Statement against payment of the consideration set forth therein, the Shares will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing opinion is limited to the laws of the State of Maryland and we do not express any opinion herein concerning any other law. We
express no opinion as to the applicability or effect of the 1940 Act or other federal securities laws, or state securities laws, including the securities laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The opinion expressed herein is limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the
matters expressly stated. We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This opinion is being furnished to you for submission to the Commission as an exhibit to the Registration Statement. We hereby consent to the
filing of this opinion as an exhibit to the Registration Statement and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section&nbsp;7 of the
1933 Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">/s/ Venable LLP</TD></TR>
</TABLE></DIV>
</DIV>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cik0001058239-20250926.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 26-September-2025 [09:18:03] {PM}-->
<schema targetNamespace="http://www.sec.com/20250926" elementFormDefault="qualified" xmlns:cik0001058239="http://www.sec.com/20250926" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cef-pre="http://xbrl.sec.gov/cef-pre/2025">
  <annotation>
    <appinfo />
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <import namespace="http://xbrl.sec.gov/cef/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/cef-pre/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g879285g0925061745048.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g879285g0925061745048.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O -,# 2(  A$! Q$!_\0
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,Z 457/#^4.67<__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th"><div>Sep. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001058239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">333-285996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="text">811-08709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">N-2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreEffectiveAmendment', window );">Pre-Effective Amendment</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PostEffectiveAmendment', window );">Post-Effective Amendment</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PostEffectiveAmendmentNumber', window );">Post-Effective Amendment Number</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="text">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Western Asset High Income Fund II Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Madison Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">17th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">777-0102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="text">From time to time after the effective date of this Registration Statement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462dFileNumber', window );">Exhibits Only, 462(d), File Number</a></td>
<td class="text">333-285996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Madison Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">17th Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Jane Trust<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462dFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462dFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>40</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d879285dposex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cik0001058239-20250926.xsd</File>
    <File doctype="POS EX" isN2Prospectus="true" isUsgaap="true" original="d879285dposex.htm">d879285dposex.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="6">http://xbrl.sec.gov/cef/2025</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d879285dposex.htm": {
   "nsprefix": "cik0001058239",
   "nsuri": "http://www.sec.com/20250926",
   "dts": {
    "schema": {
     "local": [
      "cik0001058239-20250926.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "inline": {
     "local": [
      "d879285dposex.htm"
     ]
    }
   },
   "keyStandard": 40,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 194,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 39,
    "http://xbrl.sec.gov/cef/2025": 6
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P09_26_2025To09_26_2025",
      "name": "dei:EntityFileNumber",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d879285dposex.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_26_2025To09_26_2025",
      "name": "dei:EntityFileNumber",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d879285dposex.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-25-220647-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-220647-xbrl.zip
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M:6Y/CF08,X!X<:/J3LMQ)E 9O-0QPH&F$"P@60 5VGDFT(+?R:FN-JJEZ,>
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MH)%F!5ZD2@I,Q;%+!#@G(79)T=B23;&"-8$45T;F  &F-91<B4)*H^K-*K>
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MR0MIQ66XE*6AO(%7@*<))Q_E1[$CM%[?WA4*]N>&)Y--V<X/IU\7F738PPI
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MVEA=7[^"2O* /K62<?+16@_[>4U:Y\, &E&"#5WA!90/+T#?W Z":TM\&Z%
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MEO8#'N 7?R< 1;D$,;\JEF45NS'YXU$/5L_]Y<V[O_UR"K/\R7]LUU.^T:Q
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MFE6W<G2RNUFK;S1QN/C/D?.79^IPJ.S1M"RX))HX^)(S0X!D"IHP9)II!TX
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M%116[",*>[&  ER/AZ-5Z_"$ZKE:/)E5>"I:'+C#@E"+;.Y2)D]#*&1T*I+
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M,0&H Q_)0U5AB &^2OI;$^7*(*,C9TL9EAWB,[#25::=AIB7E(RF&B^>C;[
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M7U!+ 0(4 Q0    ( %6".EOTBZ89<@(  )\(   :              "  0
M  !C:6LP,# Q,#4X,C,Y+3(P,C4P.3(V+GAS9%!+ 0(4 Q0    ( %6".EMS
MY6#QHG@   Z@ @ 1              "  :H"  !D.#<Y,C@U9&5X.3EH+FAT
M;5!+ 0(4 Q0    ( %6".ELW7)Z .PT  '4U   2              "  7M[
M  !D.#<Y,C@U9&5X.3EL,BYH=&U02P$"% ,4    " !5@CI;EZ/PE5$O  #7
MG0$ $0              @ 'FB   9#@W.3(X-61P;W-E>"YH=&U02P4&
/  0 !  & 0  9K@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d879285dposex_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cik0001058239-20250926.xsd" xlink:type="simple"/>
    <context id="P09_26_2025To09_26_2025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001058239</identifier>
        </entity>
        <period>
            <startDate>2025-09-26</startDate>
            <endDate>2025-09-26</endDate>
        </period>
    </context>
    <context id="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001058239</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-26</startDate>
            <endDate>2025-09-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="P09_26_2025To09_26_2025" id="ixv-1046">0001058239</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1047">false</dei:AmendmentFlag>
    <dei:EntityFileNumber contextRef="P09_26_2025To09_26_2025" id="ixv-1065">333-285996</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber contextRef="P09_26_2025To09_26_2025" id="ixv-1066">811-08709</dei:InvestmentCompanyActFileNumber>
    <dei:DocumentType contextRef="P09_26_2025To09_26_2025" id="ixv-1067">N-2</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="P09_26_2025To09_26_2025" id="ixv-1068">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendment contextRef="P09_26_2025To09_26_2025" id="ixv-1069">false</dei:PreEffectiveAmendment>
    <dei:PostEffectiveAmendmentNumber contextRef="P09_26_2025To09_26_2025" id="ixv-1070">1</dei:PostEffectiveAmendmentNumber>
    <dei:PostEffectiveAmendment contextRef="P09_26_2025To09_26_2025" id="ixv-1071">true</dei:PostEffectiveAmendment>
    <dei:InvestmentCompanyActRegistration contextRef="P09_26_2025To09_26_2025" id="ixv-1072">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="P09_26_2025To09_26_2025" id="ixv-1073">14</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="P09_26_2025To09_26_2025" id="ixv-1074">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:EntityRegistrantName contextRef="P09_26_2025To09_26_2025" id="ixv-1075">Western Asset High Income Fund II Inc.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="P09_26_2025To09_26_2025" id="ixv-1076">One Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="P09_26_2025To09_26_2025" id="ixv-1077">17th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="P09_26_2025To09_26_2025" id="ixv-1078">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P09_26_2025To09_26_2025" id="ixv-1079">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P09_26_2025To09_26_2025" id="ixv-1080">10010</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P09_26_2025To09_26_2025" id="ixv-1081">888</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P09_26_2025To09_26_2025" id="ixv-1082">777-0102</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="ixv-1083">Jane Trust</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="ixv-1084">One Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="ixv-81">17th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="ixv-1085">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="ixv-1086">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="P09_26_2025To09_26_2025_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"
      id="ixv-1087">10010</dei:EntityAddressPostalZipCode>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="P09_26_2025To09_26_2025" id="ixv-1088">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="P09_26_2025To09_26_2025" id="ixv-1089">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="P09_26_2025To09_26_2025" id="ixv-1090">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1091">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="P09_26_2025To09_26_2025" id="ixv-1092">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="P09_26_2025To09_26_2025" id="ixv-1093">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="P09_26_2025To09_26_2025" id="ixv-1094">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="P09_26_2025To09_26_2025" id="ixv-1095">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="P09_26_2025To09_26_2025" id="ixv-1096">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="P09_26_2025To09_26_2025" id="ixv-1097">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="P09_26_2025To09_26_2025" id="ixv-1098">true</dei:ExhibitsOnly462d>
    <dei:ExhibitsOnly462dFileNumber contextRef="P09_26_2025To09_26_2025" id="ixv-1099">333-285996</dei:ExhibitsOnly462dFileNumber>
    <cef:RegisteredClosedEndFundFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1100">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1101">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1102">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1103">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityWellKnownSeasonedIssuer contextRef="P09_26_2025To09_26_2025" id="ixv-1104">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityEmergingGrowthCompany contextRef="P09_26_2025To09_26_2025" id="ixv-1105">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="P09_26_2025To09_26_2025" id="ixv-1106">false</cef:NewCefOrBdcRegistrantFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
